other	53
the following are appropriate:	37
seizures	22
hearing loss	16
skeletal	15
cardiovascular	12
respiratory	12
dental	10
treatment includes the following:	10
gastrointestinal	9
hearing	9
the following are indicated:	9
neurologic	8
treatment is symptomatic	8
motor dysfunction	8
gross motor dysfunction	8
consider use of durable medical equipment as needed (e	8
fine motor dysfunction	8
oral motor dysfunction	8
eyes	8
skin	8
developmental pediatricians can provide assistance with transition to adulthood	8
some issues to consider:	8
renal disease	7
eye	7
sensorineural hearing loss	7
nutrition	7
growth	7
ophthalmologic	7
manifestation	7
treatment	7
communication issues	7
and	6
craniofacial	6
hypothyroidism	6
treatment is supportive	6
forearm crutches or canes for gait stability	6
special shoes, including those with good ankle support	6
5 g/m2	6
table 3	6
considerations/other	6
standard recommendations may vary from country to country	6
ages 0-3 years	6
ages 3-5 years	6
ages 5-21 years	6
all ages	6
liver transplantation	6
canes and walkers help prevent falls	6
no specific therapy is available	5
renal	5
cardiomyopathy	5
intellectual disability	5
ataxia	5
special education	5
failure to thrive	5
developmental delay	5
1-0	5
treatment is symptomatic and may include the following:	5
dystonia	5
in the united states:	5
consider evaluation for alternative means of communication (e	5
yes	5
short stature	4
endocrine	4
neurologic manifestations	4
pulmonary	4
cancer	4
physical therapy	4
renal anomalies	4
deafness	4
5-1	4
treatment follows routine practices	4
speech therapy	4
some individuals require forearm crutches or canes for gait stability	4
cardiac	4
caregivers	4
heart defects	4
psychotropic medication may also be indicated	4
constipation	4
antiepileptic drugs	4
musculoskeletal	4
spasticity	4
global developmental disability / intellectual disability educational issues	4
private supportive therapies based on the affected individual’s needs	4
medications	4
0-3	4
developmental	4
8-2	4
gerd = gastroesophageal reflux disease	4
hydrocephalus	3
adrenal insufficiency	3
hypertension	3
liver disease	3
hepatic disease	3
pulmonary disease	3
renal manifestations	3
hyperlipidemia	3
bleeding	3
dialysis	3
surgical stabilization of the spine may be required	3
pectus excavatum can be severe	3
optic atrophy	3
appropriate treatment includes the following:	3
diabetes mellitus	3
for ages 0-3 years	3
for ages 3-5 years	3
for ages 5-21 years	3
for all ages	3
social/behavioral difficulties	3
05-0	3
weight control to avoid obesity	3
feeding difficulties	3
osteopenia	3
management is supportive	3
development	3
exocrine pancreatic insufficiency	3
anemia	3
malignancy	3
exercise within the individual's capability	3
fewer than 5% need wheelchairs	3
symptomatic treatment	3
5-0	3
0 g/m2	3
audiologic	3
fitting with appropriate hearing aids	3
enrollment in an appropriate educational program for the hearing impaired	3
growth hormone deficiency	3
tolerance to different primary layers varies	3
nonstick products (e	3
silicone-based products without adhesive (e	3
rolls of gauze (e	3
cleft palate	3
table 5	3
neutropenia	3
physical therapy is recommended to maximize mobility	3
no specific treatment is available	3
prevention of secondary manifestations	3
ketogenic diet	3
7-2	3
pediatric issues	3
liver	3
sodium benzoate	3
table 4	3
orthopedic	3
supportive therapy includes the following:	3
use of respiratory aids when indicated	3
genitourinary abnormalities	3
epilepsy	3
see hereditary hearing loss and deafness	3
supportive and symptomatic management is indicated	3
9-2	3
2(1	3
0(1	3
5-2	3
7-4	3
surgery	3
dysphagia	3
vision	3
hypogonadism	3
care by a pediatric endocrinologist is recommended	3
standard management	3
craniosynostosis	2
org)	2
obesity	2
obstructive sleep apnea	2
ocular	2
cleft lip/palate	2
chronic treatment	2
hypogonadotropic hypogonadism	2
other treatments	2
movement disorder	2
lung disease	2
no definitive treatments for the limb-girdle muscular dystrophies exist	2
thrombocytopenia	2
reducing the risk of neurologic damage	2
see deafness and hereditary hearing loss overview, management	2
immunodeficiency	2
some symptoms (e	2
bone marrow transplantation	2
symptoms typically resolve within days	2
bone marrow transplantation (bmt)	2
education of parents regarding common seizure presentations is appropriate	2
, contractures, scoliosis, hip dislocation)	2
parkinsonism	2
other features	2
ovarian insufficiency	2
infertility	2
cardiac defects are managed in a routine manner	2
the following are recommended:	2
precocious puberty	2
physical therapy and rehabilitation to improve motor function	2
they can tolerate carbohydrates, fats, and protein	2
oral motor dysfunction with persistent vomiting	2
consultation with a gastroenterologist and nutritionist is often necessary	2
"infantile catastrophic phase	2
strabismus	2
stroke-like episodes	2
coagulopathy	2
deep venous thrombosis (dvt)	2
independent living issues	2
0-2	2
ocular manifestations	2
aeruginosa in airway cultures	2
bronchodilator	2
hypertonic saline	2
dornase alfa	2
airway clearance	2
fertility	2
refractive errors may be managed with spectacles or contact lenses	2
to improve alignment in primary gaze position	2
colitis	2
antidepressants are often required to treat concurrent depression	2
ocular abnormalities	2
services provided vary based on age and needs	2
physical and occupational therapy	2
ventilatory support	2
daily heel cord stretching exercises to prevent achilles tendon shortening	2
orthopedic surgery	2
fewer than 5% of individuals need wheelchairs	2
respiratory dysfunction	2
odontoid hypoplasia	2
exercise within the individual's capability to remain physically active	2
hearing aids as needed	2
management includes the following:	2
0 mm in diameter	2
pharmacologic treatment	2
central nervous system	2
cognitive	2
endocrinopathies	2
spine	2
sodium benzoate: 250 mg/kg or 5	2
sodium phenylacetate: 250 mg/kg or 5	2
10% arginine hcl: 600 mg/kg or 12	2
reversal of catabolism	2
gastroesophageal reflux should be addressed in a standard manner	2
ophthalmologic abnormalities are treated in the standard manner	2
skeletal abnormalities (e	2
hearing loss is treated with a trial of hearing aids	2
infants benefit from enrollment in an early-intervention program	2
pulmonary fibrosis	2
thiamine	2
riboflavin	2
initial treatment	2
long-term medical management	2
levodopa	2
treatment of psychiatric problems with appropriate psychotropic medications	2
adaptation of environment and care to the level of dementia	2
individuals with severe heart block may require pacemaker implantation	2
growth retardation	2
feeding therapy	2
oral medications are usually tried first:	2
baclofen (lioresal®)	2
benzodiazepines	2
primary layers include the following:	2
, telfa®, n-terface®)	2
, mepitel®, mepilex®)	2
, kerlix®) are commonly used	2
hypotrichosis	2
see prevention of primary manifestations	2
hematologic	2
treatment of manifestations in individuals with ethylmalonic encephalopathy	2
gorman et al [2016]	2
enrollment in developmental disabilities administration (dda) is recommended	2
hernia	2
arterial abnormalities	2
acute photosensitivity	2
grey or smoke-colored filters provide only partial protection	2
topical sunscreens are typically not useful	2
close monitoring is warranted	2
treatment of thrombosis in children	2
antoun et al [2016]	2
huemer et al [2015]	2
the following measures are appropriate:	2
referral of the family to support groups and other resources	2
cryptorchidism	2
dental problems	2
pain	2
thus, good sleep hygiene should be encouraged	2
corticosteroids	2
immunoglobulins	2
educational programming directed to the specific disabilities identified	2
cardiac manifestations	2
intramuscular injections should be avoided unless under factor coverage	2
dermatologic	2
cataract	2
250 mg/kg/day	2
sodium phenylacetate	2
mechanisms of drug action in treatment of hyperammonemia	2
raises insulin levels	2
induces anabolic state	2
causes protein sparing effect from skeletal muscle amino acids	2
stimulates secretion of insulin	2
eliminates one amino group in the urine	2
eliminates two amino groups in the urine	2
a non-essential amino acid in humans	2
surgical management	2
renal and liver function	2
full blood count	2
psychological support	2
table 7	2
principles of treatment for individuals with hokpp	2
add 0	2
3 meq/kg/h	2
(2) in the work setting	2
myopathy	2
behavior	2
drugs to reduce muscle spasticity (e	2
, oxybutynin)	2
cd46	2
cfh	2
dgke	2
thbd	2
hyperuricemia/gout	2
lifelong therapy with allopurinol may be required	2
the transplanted kidney does not develop the disease	2
current recommended drug therapies for adults with fh	2
15% 1, 3	2
50% 5	2
often ineffective in hofh	2
kastelein et al [2008]	2
rader et al [2003]	2
approved only for adults with hofh	2
cuchel et al [2014]	2
raal & santos [2012]	2
physical therapy to improve motor function	2
pharmacologic treatment of spasticity and seizures	2
maintenance therapy	2
genital anomalies	2
surgery as required	2
routine management	2
thyroid hormone replacement as needed	2
treatment of manifestations in individuals with kcnk9 imprinting syndrome	2
standard treatment for scoliosis	2
developmental disabilities administration (dda) enrollment is recommended	2
social/behavioral issues	2
therapeutic management of the sleep disorder	2
management of seizures in accordance with standard practice	2
auditory amplification if hearing loss is identified	2
gonadotropin therapy	2
spastic paraplegia	2
general guidelines can be followed	2
antiepileptic drugs (aed) if epileptic seizures are present	2
acidosis	2
psychological support for the affected individual and family is essential	2
feeding	2
psychomotor development	2
gerd	2
neurobehavioral symptoms	2
the choice should be left to personal preference	2
dural ectasia is usually asymptomatic	2
no effective therapies for symptomatic dural ectasia currently exist	2
hernias tend to recur after surgical intervention	2
long-term treatment	2
genitourinary	2
joint contractures	2
developmental delay/cognitive impairment	2
specialized learning programs to meet individual needs	2
no specific antiepileptic or antipsychotic medications are indicated	2
cardiac malformations	2
treatment should follow standard practice	2
see hereditary hearing loss and deafness overview	2
congenital heart defects	2
stretching exercises are ineffective and painful	2
the following treatment is appropriate:	2
joints	2
reasons for 28 hospitalizations in 15 infants with msud	2
strauss et al [2010]	2
4(2	2
3(1	2
1(1	2
5-6	2
3-9	2
3-1	2
0(3	2
7(3	2
7-7	2
2(5	2
50(0	2
43-0	2
58)	2
from strauss et al [2010]	2
with permission from elsevier	2
acute pancreatitis	2
infection	2
see hirschsprung disease overview	2
cataracts	2
deep brain stimulation (dbs)	2
cataracts can be removed if they impair vision	2
other tumors	2
photodysphoria (discomfort in bright light	2
orthopedic treatment	2
dental treatment	2
treatment of decreased visual acuity is symptomatic (e	2
, low-vision aids)	2
250 mg/kg	2
5,500 mg/m2	2
batshaw et al [2001]	2
loading dose given over 90 to 120 minutes	2
maintenance dose given over 24 hours	2
the typical dilution is 1:10	2
arginine infusion not to exceed 150mg/kg/h	2
surgery has been reported to be helpful by many patients	2
fecal elastase-1 analysis (schebo® biotech ag	2
, cck-8) or receptor agonists (e	2
their nature (e	2
blocking of pancreatic lipase (e	2
diseases of the intestinal mucosa	2
diffusion-weighted mri	2
monitoring for glucose intolerance	2
hypoventilation	2
consider aspirin treatment	2
severe atp8b1 deficiency	2
mild atp8b1 deficiency	2
reduction of calcium oxalate supersaturation	2
organ transplantation	2
only if affected person is known to be b6 responsive	2
from cochat et al [2012]	2
recommendations assume the availability of facilities	2
pox= plasma oxalate	2
see note	2
visual impairment	2
cys282tyr / p	2
treatment of medical manifestations in individuals with ptls	2
standard treatment as recommended by dentist/orthodontist	2
poor weight gain / failure to thrive	2
global developmental delay / intellectual disability educational issues	2
, orthotics, adaptive strollers)	2
chemotherapy	2
5 years	2
joint pain	2
see published guidelines/consensus statements	2
treatment of manifestations in individuals with pura-related neurodevelopmental disorders	2
scoliosis	2
sleep	2
skeletal abnormalities	2
treatments include the following:	2
standard treatment with antiepileptic drugs for seizures	2
physical, occupational, and speech therapies, if necessary	2
standard treatment is indicated	2
treatment of manifestations in individuals with trio-related intellectual disability	2
treatment of manifestations in individuals with unc80 deficiency	2
see retinitis pigmentosa overview, management	2
educational support	2
hearing impairment	2
medical measures	1
early use of antibiotics for bacterial infections	1
insertion	1
physiotherapy including hydrotherapy to avoid strain on the joints	1
use of a wheelchair if necessary	1
orthopedic intervention if necessary	1
special shoes may help with ankle and foot support	1
therefore, ventriculocaval shunts are preferred	1
educational opportunities/social considerations	1
use of sign language in individuals with significant hearing loss	1
early educational intervention for development of social skills	1
speech therapy to improve speech	1
special education to maximize learning	1
planning housing for possible future wheelchair use	1
hbh disease	1
cortisol deficiency	1
genital abnormalities	1
hypospadias and cryptorchidism may be corrected with surgery	1
vaginal reconstruction may be performed in females with vaginal hypoplasia	1
ovarian cysts	1
nasal stints or tracheotomy may be required	1
joint contractures and elbow synostosis	1
early developmental/educational intervention is appropriate for cognitive delays	1
low-dose neuroleptics may be useful for psychiatric manifestations	1
referral for psychiatric evaluation is appropriate	1
low vision aids include high-powered magnifiers for reading	1
achromat	1
provide palliative care for viable newborns	1
only modest effects on adult stature seem to accrue	1
measures to avoid obesity should start in early childhood	1
craniocervical junction constriction	1
the best predictors of need for suboccipital decompression include:	1
lower-limb hyperreflexia or clonus	1
central hypopnea demonstrated by polysomnography	1
treatment may include the following:	1
adenotonsillectomy	1
weight reduction	1
continuous positive airway pressure	1
tracheostomy for extreme cases	1
middle ear dysfunction	1
varus deformity	1
various interventions may be elected (e	1
kyphosis	1
spinal stenosis	1
socialization	1
desferrioxamine	1
treatment with iron chelating agents (i	1
deferasirox	1
deferiprone	1
fresh-frozen human plasma	1
if the serum potassium concentration is low (<3	1
treatment for actg2-related disorders remains supportive	1
urologic manifestations	1
management of bladder dysfunction by an urologist is recommended	1
gastrointestinal manifestations	1
however, bladder catheterization was still required	1
prophylaxis for pneumocystis jiroveci	1
intravenous immunoglobulin (ivig)	1
cutaneous/cranial	1
wounds without calvarial involvement	1
plastic wrap (e	1
, duoderm®)	1
other less preferred, less costly dressings are:	1
wounds with calvarial defects: acute care	1
wounds with calvarial defects: late calvarial reconstruction	1
limb	1
early physiotherapy can maximize motor function and range of motion	1
management of seizures is per routine	1
if typical signs (e	1
medication has been variably effective in suppressing debilitating symptoms	1
j friedman, personal observation]	1
fm hisama, personal observation]	1
stress management	1
intrafamilial variation in pharmaco-responsiveness occurs	1
therefore, all appropriate aeds should be tried	1
speech, occupational, and physical therapy	1
specialized learning programs depending on individual needs	1
nutritional support if necessary	1
routine treatment of cardiac and ophthalmologic findings	1
ankyloblepharon filiforme adnatum	1
larger ones may require surgical separation by an ophthalmologist	1
ectodermal defects	1
skin erosions	1
empiric treatment (i	1
clefting should be addressed as soon as developmentally possible	1
chest physiotherapy and vigorous treatment of respiratory complications	1
management of seizures using standard protocols	1
acute episodes	1
correction of hyperkalemia may be needed	1
, solu-cortef®)	1
adequate sodium must be provided	1
treatment during stress	1
, intercurrent illness, surgery, trauma)	1
glucose and sodium may be needed	1
parents should have access to rapid medical advice	1
guidelines for hospital admission should be clear	1
acth levels should normalize when replacement therapy is adequate	1
acute neurovisceral attack	1
clinical assessment should include a full neurologic evaluation	1
investigations should include:	1
full blood count (fbc)	1
serum and urine osmolality	1
urine sodium concentration if hyponatremic	1
, crp, blood cultures, ck, magnesium	1
mri should be considered if cns symptoms are present	1
general measures	1
see agents/circumstances to avoid	1
restore energy balance using an enteral route if possible	1
treat intercurrent infections and other diseases promptly	1
supportive treatment	1
pain relief	1
nausea and vomiting	1
prochloperazine, promazine or ondansetron are considered safe	1
beta blockers are considered safe	1
fluid balance and electrolytes	1
dextrose saline is preferred	1
specific treatment	1
it is infused over at least 30 minutes	1
recurrent acute attacks	1
gynecological review and bone density monitoring are recommended	1
prophylactic hemin infusion	1
however, evidence for clinical efficacy remains elusive	1
, medicalert® or similar)	1
see resources	1
liver transplantation for end-stage liver disease has an 80	1
cardiac involvement is treated in a standard manner	1
renal anomalies are treated in a standard manner	1
vascular accidents should be treated in a standard manner	1
head injuries and neurologic symptoms should be evaluated aggressively	1
ophthalmologic abnormalities rarely need intervention	1
vertebral anomalies are rarely symptomatic	1
no specific therapy is currently available for alexander disease	1
neuroblastoma and ganglioneuroblastoma	1
aortic stenosis may necessitate valve replacement	1
treatment is limited to symptom management and supportive care	1
alpers-huttenlocher syndrome	1
family education is critical	1
supportive therapies	1
hepatic	1
treatment with cpap or bipap as indicated is appropriate	1
seizure control is a goal of treatment	1
other phenotypes	1
gastrostomy may be required to provide adequate nutrition	1
surgery for ptosis may provide symptomatic relief for some	1
, influenza and pneumococcal)	1
controls	1
recommend intravenous aat augmentation therapy for individuals with established emphysema	1
, fev1 35%-60% predicted)	1
2 months post-liver transplant and not achieving statistical significance	1
panniculitis	1
hypertensive individuals should receive appropriate management	1
male relative without hematuria	1
male relative with hematuria	1
female relative without hematuria	1
female relative with hematuria (i	1
, heterozygous female)	1
cochlear	1
hearing aids should be prescribed when appropriate	1
some individuals develop cataracts that interfere with vision	1
these should be extracted when necessary	1
diffuse leiomyomatosis	1
symptomatic leiomyomas may require surgical intervention	1
monitoring for and treatment of lymphoproliferation and hypersplenism	1
however, sirolimus is not without side effects	1
treatment of lymphoma is according to conventional protocols	1
treatment of cytopenias and other autoimmune diseases	1
caregiver and patient support groups are valuable	1
options include:	1
ssris	1
venlafaxine	1
however, weakness and lethargy are common side effects	1
low-tech (e	1
, alphabet board) and high-tech (i	1
no therapy exists to prevent the progressive organ involvement	1
rod-cone dystrophy	1
progressive sensorineural hearing loss	1
hearing can be maximized with bilateral digital hearing aids	1
exercise	1
and metformin	1
hypertriglyceridemia	1
pancreatitis should be treated as in the general population	1
urologic	1
prevention of primary complications	1
depression and seizures should be treated with appropriate medications	1
the first such drug was tacrine	1
however, this agent is also hepatotoxic	1
antidepressant medication may improve associated depression	1
seizures have occurred in some affected infants	1
assignment of sex of rearing	1
even in cais this may not always be easy	1
cais	1
however, the issue of gonadectomy is controversial	1
pais with predominantly female genitalia (incomplete ais)	1
pais with ambiguous genitalia or predominantly male genitalia	1
gynecomastia that develops in puberty eventually requires reduction mammoplasty	1
mais	1
the customary medical treatment (i	1
sometimes fundoplication as required	1
no one drug has proven superior	1
medications used for minor motor seizures (e	1
hypermotoric behaviors are typically resistant to behavioral therapies	1
unstable or nonambulatory children may benefit from physical therapy	1
individualization and flexibility in the school are important educational strategies	1
administration of 0	1
strabismus may require surgical correction	1
aniridia	1
simple measures are often the most important:	1
regular eye examinations and correction of refractive errors	1
occlusion therapy for anisometropic amblyopia or strabismic amblyopia in childhood	1
advice and help with schooling	1
social support	1
lens	1
children rarely require surgery (lens aspiration or lensectomy)	1
in adults, phacoemulsification can be successful	1
intraocular pressure	1
glaucoma is usually initially treated with topical anti-glaucoma medication	1
trabeculectomy with or without antimetabolites (e	1
medical treatment is generally ineffective and surgery is required	1
cornea	1
aniridic fibrosis syndrome	1
wilms tumor	1
see wilms tumor overview	1
the need for orthoses or other assistive devices varies individually	1
most patients remain ambulatory without assistance for decades	1
provide palliative care for the viable newborn	1
educational support (e	1
, behavioralists) who can provide the following:	1
gait safety devices including canes and wheel chairs	1
behavioral modification and cognitive aids as needed	1
there are no formal management guidelines for apoe p	1
leu167del-related lipid disorders	1
in patients with fasting triglyceride levels:	1
splenomegaly	1
splenectomy should be avoided as it may worsen hyperlipidemia	1
liver function abnormalities	1
persistent nausea	1
vomiting	1
abdominal pain	1
yellow discoloration of the skin	1
bruising	1
any new petechial rash	1
allopurinol	1
febuxostat	1
treatment of esrd	1
kidney transplantation	1
arginine supplementation is obviously contraindicated	1
rapidly reducing plasma ammonia concentration	1
pharmacologic management to allow alternative pathway excretion of excess nitrogen	1
in early treatment, feeding 1	1
0 to 1	1
older children require and tolerate lower protein intake	1
seizures are easily treated by phenobarbital or carbamazepine	1
discontinuing oral protein intake	1
intravenous nitrogen scavenging therapy	1
ammonia levels usually normalize with therapy	1
nitrogen scavenging therapy needs to be continued during hemodialysis	1
curative therapy is not available	1
clinical history studies are limited	1
aneurysms and focal stenoses are amenable to surgical intervention	1
hernias may recur after surgical repair	1
emphysema is treated symptomatically	1
, swimming) performed in moderation	1
no treatment is available	1
see hereditary ataxias, management	1
beta blockers are considered first line therapy	1
however, individual responses to specific medications (e	1
(see also therapies under investigation	1
speech therapy may benefit persons with dysarthria	1
one of the following vitamin e preparations is used:	1
the naturally occurring form, rrr-α-tocopherol	1
thalassemia major	1
transfusions are usually given every two to three weeks	1
thalassemia intermedia	1
cord blood transplantation	1
uveal melanoma	1
malignant mesothelioma	1
thus, a cure is unlikely	1
there is no specific treatment of bwcff syndrome	1
symptomatic management involves the following	1
ptosis may require surgical treatment	1
hearing loss may require routine care including hearing aids	1
epilepsy is treated using standard protocols	1
management of heart failure	1
management of neutropenia	1
78 ± 0	1
45-12	1
8 years, with an average exposure of 7	1
3 years	1
educational support in school	1
, renal or hepatic dysfunction)	1
indicators are functional interference and poorly fitting footwear	1
dental extractions are appropriate as required for dental crowding	1
insertion of grommets is commonplace	1
manifestations should be treated by specialists (e	1
keratocysts usually require surgical excision	1
systemic treatment with retinoids (e	1
bethlem myopathy	1
ullrich cmd	1
contractures tend to be aggressive and may require surgery	1
kcnq2-bfne	1
refractory seizures are uncommon in kcnq2-related bfne	1
kcnq2-nee	1
augmentative communication techniques can be valuable for many patients	1
antiepileptic treatment for seizures	1
symptomatic treatment for headaches	1
biotin and thiamine therapy	1
biotin and thiamine need to be given lifelong	1
in the acute stage empiric treatment with antimicrobial/antiviral agents	1
fever control	1
antiepileptic drugs for effective control of seizures	1
symptomatic treatment of dystonia, including administration of l-dopa	1
rehabilitation, physiotherapy, occupational therapy, and speech therapy	1
educational programs adapted to individual needs	1
therefore, renal tumors greater than 3	1
no treatment for bcd currently exists	1
psychosocial	1
milunsky et al [2011] provided management guidelines	1
see table iii)	1
they should not be cauterized	1
most larger skin defects require surgical excision	1
recommended treatment:	1
second branchial arch anomalies	1
excise branchial cleft cysts/fistulae	1
otologic anomalies	1
fit with appropriate aural habilitation as indicated	1
enroll in an appropriate educational program for the hearing impaired	1
consider canaloplasty to correct an atretic canal	1
treat urologic and renal abnormalities in the standard manner	1
if renal anomalies (e	1
if esrd develops, consider renal transplantation	1
global developmental disability/intellectual disability	1
disordered sleep	1
ophthalmologic findings	1
eye findings are treated in a routine manner	1
regular pulmonary hygiene to manage risk for pulmonary complications	1
tracheostomy as indicated when secretions are difficult to manage	1
eyelid surgery	1
timing of eyelid surgery is controversial	1
however, it remains controversial	1
hormone replacement therapy (hrt)	1
it is important to:	1
controversy exists regarding the treatment of asymptomatic individuals	1
treatment of craniofacial manifestations (e	1
there are no reports on the use of aflibercept	1
the cnv regressed and the subretinal hemorrhage resolved	1
genetic counseling and occupational counseling should be offered	1
abdominal wall repair for omphalocele soon after birth	1
generally, this surgery is well tolerated	1
management of difficulties arising from macroglossia:	1
some children benefit from tongue reduction surgery	1
orthodontic intervention as needed in later childhood/adolescence	1
assessment of speech difficulties	1
management of cleft palate following standard protocols	1
referral to a craniofacial surgeon if facial hemihyperplasia is significant	1
treatment of neoplasias following standard pediatric oncology protocols	1
, nephrocalcinosis)	1
management of cardiac problems following standard protocols	1
during acute episodes	1
restrict protein intake if plasma ammonia is elevated	1
without carglumic acid, hyperammonemia persisted longer (i	1
, an additional 1-2 days)	1
there is no treatment of proven efficacy for cadasil	1
classic 21-ohd cah	1
glucocorticoid replacement therapy	1
the use of oral hydrocortisone suspension is discouraged	1
during periods of stress (e	1
affected individuals should carry medical information regarding emergency steroid dosing	1
mineralocorticoid replacement therapy	1
sodium chloride supplementation may not be necessary after infancy	1
feminizing genitoplasty	1
the systematic evidence for this belief is lacking	1
testicular adrenal rest tumors	1
transition from adolescence to adulthood	1
women with classic cah had increased diastolic blood pressure	1
subjective health status was significantly impaired and fertility compromised	1
adrenalectomy	1
non-classic 21-ohd cah	1
most survivors with cd require orthopedic care	1
club feet require surgical correction	1
the hips should be checked for luxation	1
bracing is usually not helpful	1
neonatal/infantile canavan disease	1
seizures may be treated with antiepileptic drugs (aeds)	1
diamox® seems to reduce intracranial pressure	1
botox® injections may be used to relieve spasticity	1
mild/juvenile canavan disease	1
scoliosis may require bracing or surgical correction	1
personality change may require antipsychotic medication	1
a wig or hairpiece may be helpful for alopecia	1
the following interventions are routine:	1
cardiac myxoma	1
open-heart surgery	1
cutaneous and mammary myxoma	1
surgical excision	1
cushing syndrome	1
bilateral adrenalectomy	1
pituitary adenoma	1
transsphenoidal surgery	1
thyroid adenomas	1
surgery if cancerous	1
lccsct	1
pms	1
surgery to remove primary and/or metastatic lesions	1
no specific treatment is currently available for caveolinopathies	1
management should include the following:	1
infants are started with daily 1	1
0 mg intramuscular or subcutaneous injections	1
acute metabolic decompensation	1
long-term management	1
these are accomplished by:	1
parenteral ohcbl	1
0 mg (~0	1
betaine	1
optimal dosing and monitoring have not been adequately established	1
folate and folinic acid	1
the adult dose of folate is 1	1
5 mg for maintenance	1
dietary management	1
other therapeutic considerations that have not been fully validated:	1
methionine supplementation	1
pyridoxine	1
levocarnitine	1
indicated for low plasma carnitine levels	1
supportive therapy includes the following as needed:	1
treatment of headache	1
guidance for visual impairment	1
classic cca	1
this type of therapy is best instituted in childhood	1
surgical release of contractures may be necessary	1
consultation with an orthopedist is encouraged	1
severe/lethal cca	1
no general recommendations exist	1
speech therapy may be required during periods of dental treatment	1
sinus and middle ear infections require aggressive and timely treatment	1
helmets may be advised for high-risk activities	1
the treatment of cataracts is surgical	1
regular rehabilitation can prevent or postpone osteoporosis	1
recurrent hemorrhage or mass effect	1
neuropsychological testing may be considered prior to any neurosurgical procedure	1
microsurgical techniques rely on intraoperative examination for precise localization	1
headaches	1
neurologic deficits	1
hypotonia and weakness	1
patients may benefit from physical therapy	1
scoliosis and joint contractures	1
patients with more severe symptoms may require respiratory support	1
peginterferon-α2b has also been given once a week	1
the mechanism behind this response is unknown	1
splenectomy is of unproved value	1
orthopedic issues—thorax shortening, scoliosis/kyphosis	1
occasionally, surgical treatment of spinal curvature is warranted	1
others may have a more refractory course	1
renal issues	1
immunologic status	1
most individuals affected with cdgs have functional immune systems	1
additional management issues of adults with cdg	1
orthopedic issues — thorax shortening, scoliosis/kyphosis	1
recently, therapy may start in the prenatal period	1
postnatal treatment	1
emphasis must be on preventing secondary lung injury	1
it is unclear whether ecmo improves survival in cdh	1
prenatal treatment	1
surgical correction of intestinal malrotation if present	1
alternative communicative methods (e	1
standard treatment for hearing loss	1
standard interventions for cardiac defects	1
appropriate treatment for seizures	1
antibiotic prophylaxis and follow up for vesicoureteral reflux	1
orchiopexy if cryptorchidism is present	1
standard intervention for bicornuate uterus, if present	1
cervical spine stenosis may require decompression	1
thoracic and lumbar spine (for scoliosis)	1
l-carnitine supplementation	1
l-carnitine supplementation has relatively few side effects:	1
hypoglycemic episodes are treated with intravenous dextrose infusion	1
cardiomyopathy requires management by specialists in cardiology	1
correction of polydactyly (optional)	1
orthopedic care as required (e	1
, for hip dysplasia)	1
dental care	1
standard treatment for renal and liver abnormalities	1
pneumonia should be treated with antibiotics	1
asthma can be treated with steroids	1
standard treatment for cardiac abnormalities	1
no consensus management guidelines have been developed to date	1
improving gait, exercise tolerance, and flexion contractures	1
unsuccessful steroid therapy was reported in one adult	1
less symptomatic individuals can be started on 0	1
0 mg/kg every other day	1
higher-dose steroids may help with acute pain crises	1
calcitonin	1
losartan	1
pain in the tibia resolved completely following the surgery	1
corticosteroids may delay skull hyperostosis and cranial nerve impingement	1
three underwent internal auditory canal decompression with mixed results	1
celiac disease	1
a dietitian experienced in treating celiac disease should be involved	1
, 100 mg) can damage the small intestine	1
note that a slice of bread contains approximately 2	1
5 grams of gluten	1
some hidden sources of gluten:	1
non-starchy foods such as soy sauce and beer	1
, lipstick)	1
refractory sprue or celiac disease	1
cutaneous photosensitivity	1
reflectant sunscreens containing zinc oxide or titanium dioxide	1
skin trauma should be avoided	1
wound care is essential to prevent infection of opened blisters	1
laser hair removal can be used to treat facial hypertrichosis	1
topical antibiotics for corneal ulcers, scleritis, and blepharitis	1
bone manifestations	1
hemolytic anemia	1
consider blood transfusions when hemolysis is significant	1
cystic fibrosis (cf)	1
inhaled dornase alfa in all individuals age ≥6 years	1
inhaled hypertonic saline in all individuals age ≥6 years	1
recommended sequence for inhaled medications:	1
an aerosolized antibiotic	1
gly551asp and other specific pathogenic variants	1
phe508del	1
lung or heart/lung transplantation	1
an option for some individuals with severe disease	1
oral pancreatic enzyme replacement with meals	1
congenital absence of the vas deferens (cavd)	1
prevention of primary manifestations – cystic fibrosis	1
aerosolized antibiotic	1
all routine immunizations should be given at the recommended times	1
pancreatic enzyme replacement and supplementation of fat-soluble vitamins	1
high-calorie, high-fat nutritional supplements	1
consultation with a nutritionist specializing in cf	1
surveillance – cystic fibrosis	1
culture respiratory tract secretions at least four times yearly	1
75 g/kg, or 75 g maximum	1
evaluate bone mineral density in adolescence	1
agents/circumstances to avoid – cystic fibrosis	1
avoid the following:	1
respiratory irritants (e	1
, smoke, dust)	1
individuals with respiratory infections	1
dehydration	1
increasing caloric intake may be of benefit	1
constipation affects the majority of individuals	1
seizures are treated as in the general population	1
recurrent otitis media may require placement of pe tubes	1
hyperkeratoses are treated as in the general population	1
nonsurgical treatment of ophthalmologic findings:	1
correction of ptosis	1
eye muscle surgery	1
to correct or improve a compensatory head posture	1
to improve ambulation and gross motor development in young children	1
principles of surgical approach:	1
profound weakening procedures (e	1
orthodontic evaluation and appropriate intervention may be necessary	1
treatment of colitis in cgd can be difficult	1
corticosteroid treatment of heightened inflammatory response	1
granulocyte infusions	1
granulocyte infusions are generally well tolerated	1
males with x-linked cgd	1
, they are kell negative)	1
kell-negative blood products are rarely available	1
splints can be tried for foot drop	1
choanal atresia	1
feeding/swallowing dysfunction	1
renal evaluation	1
renal ultrasound examination is recommended in all children	1
endocrine evaluation	1
coloboma	1
hearing loss should be assumed until proven otherwise	1
communication	1
deaf-blind service referral	1
referral to deafblind education services (e	1
frequent rest breaks may be needed	1
myofacial release can improve posture and flexibility	1
occasionally, sleep studies show obstructive apnea	1
gi consultation is often indicated	1
obsessive-compulsive disorder	1
pervasive developmental disorder	1
sensory processing issues are likely implicated	1
attention-deficit hyperactivity disorder	1
understanding this is critical to devising appropriate interventional strategies	1
general	1
adequate nutrition and weight maintenance are essential	1
appropriate bracing and stretching can minimize contractures	1
mitochondrial myopathy	1
assistance with ambulation and posture	1
surgical correction of ptosis as needed	1
amyotrophic lateral sclerosis	1
(als)	1
frontotemporal dementia (ftd)	1
spinal motor neuronopathy	1
seizures should be managed by an experienced pediatric neurologist	1
hematologic and immunologic defects	1
select individuals may also receive intrathecal methotrexate and prednisilone	1
once remission occurs, prompt hsct is recommended	1
correction of refractive errors may improve visual acuity	1
skin hypopigmentation	1
skin protection varies depending on the degree of hypopigmentation	1
neurologic abnormalities	1
skeletal dysplasia	1
orthopedic surgery may be complicated by low bone density	1
immunodeficiency and infection	1
nutrition and ocular health have become increasingly topical:	1
preparedness for appropriate countermeasures (e	1
an apnea monitor is recommended	1
anticonvulsants may be required	1
surgical instrumentation or prolonged	1
bracing may be required to correct a progressive thoracolumbar scoliosis	1
paradoxical sweating	1
treatment should be reserved for adults and older children	1
clonidine	1
oral clonidine, at starting doses of 0	1
05 mg to 0	1
1 mg four times daily may be required	1
abrupt cessation of clonidine can lead to prominent hypertension	1
moxonidine was well tolerated in the short term	1
however, long-term observations are not yet available	1
niccd	1
the treatment with therapeutic formulas is not lifelong	1
fttdcd	1
ctln2	1
other treatments include the following:	1
saheki et al 2010	1
yazaki et al 2010	1
ohura et al, personal communication	1
okano et al, personal communication]	1
aro	1
adoii	1
orthopedic treatment is often required for fractures and arthritis	1
no specific dietary or other metabolic treatment is available	1
a trial of antiepileptic drugs (aeds) (e	1
treatment of behavioral problems is standard and requires periodic reassessment	1
no definitive treatments exist for the congenital muscular dystrophies	1
speech therapy may be indicated	1
close attention to oral hygiene is indicated	1
medical treatment	1
acetylcholineesterase (ache) inhibitors (pyridostigmine)	1
3,4-diaminopyridine (3,4-dap)	1
quinidine, fluoxetine	1
however, it may induce suicidal ideation	1
non-medical treatment	1
orthotics or a wheelchair	1
a percutaneous gastric tube	1
exercise within the affected individual's capability	1
note: (1) fatigue may improve with exercise	1
wheelchair for mobility because of gait instability	1
lower urinary tract involvement [krhut et al 2014]	1
vocal cord paresis	1
treatment may include:	1
ankle/foot orthoses	1
forearm crutches or canes	1
rarely, wheelchairs	1
career and employment counseling	1
anticipatory counseling is appropriate	1
forearm crutches or canes for gait stability for some individuals	1
many remain physically active	1
the following may be indicated:	1
wheelchairs for mobility because of gait instability	1
for treatment of findings common to all	1
trpv4-associated disorders	1
pain and depression	1
neuropathy	1
vocal cord involvement	1
respiratory therapy/support (e	1
, bipap)	1
physical therapy/exercise to maintain as much function as possible	1
orthopedic evaluation with consideration of surgical intervention (i	1
patients undergoing surgical fusion typically do well	1
appropriate treatment includes:	1
prosthetic and adaptive devices for weak hands	1
ankle/foot orthoses to correct foot drop and aid walking	1
fewer than 5% of affected individuals need wheelchairs	1
treatment of spinal deformities	1
physiotherapy helps to preserve flexibility	1
treatment of foot deformities	1
physiotherapy to preserve flexibility	1
treatment of pain and cramps	1
, pregabalin, gabapentin)	1
cramps can be controlled with quinine	1
some need wheelchairs	1
surgery to correct spine deformities	1
wheelchairs as needed because of gait instability	1
no specific treatment reverses the manifestations of cmt4j	1
severely affected individuals need wheelchairs	1
bipap for those with respiratory muscle weakness	1
peripheral neuropathy	1
see charcot-marie-tooth hereditary neuropathy overview, management	1
individualized educational program for developmental delay	1
feeding gastrostomy tube placement for failure to thrive	1
management of hearing loss	1
management of cataracts and other ophthalmologic complications	1
use of sunscreens for cutaneous photosensitivity	1
use of sunglasses for lens and retina protection	1
spectacle correction of refractive errors	1
psychosocial support for affected individuals and their families	1
recurrent infections should be treated per standard therapy	1
no specific support exists for individuals with col4a1-related disorders	1
seizures are managed using standard protocols	1
glaucoma is initially treated with topical anti-glaucoma medication	1
coenzyme q10 supplementation	1
coq4-related coenzyme q10 deficiency	1
coq6-related coenzyme q10 deficiency	1
homozygotes for the pathogenic variants p	1
gly255arg or p	1
ala353asp responded [heeringa et al 2011]	1
coq8b-related coenzyme q10 deficiency	1
pdss2-related coenzyme q10 deficiency	1
coq8a-related coenzyme q10 deficiency	1
coq9-related coenzyme q10 deficiency	1
most infants require nasogastric or gastrostomy feeding	1
pyloric stenosis is treated surgically	1
anecdotally, affected children have very high caloric needs	1
kyphoscoliosis may require surgical correction	1
dental abnormalities should be addressed by a pediatric dentist	1
papillomata	1
thus, cortisol deficiency may also be considered	1
malignant tumors	1
treatment of malignant tumors follows standard protocols	1
info and ghr	1
nlm	1
nih	1
gov	1
current treatment for long-chain fatty-acid oxidation disorders:	1
avoid known triggers	1
treatment consists primarily of surgical intervention	1
cytokine administration may shorten the consolidation period	1
timing of subsequent craniofacial surgeries influences their success	1
limbs	1
behavior therapy for behavior problems by developmental pediatrician	1
seizure management with antiepileptic drugs by epilepsy specialist	1
treatment of movement disorder by movement disorder specialist	1
gamt deficiency	1
treatment is as follows:	1
4-0	1
8g/kg/day)	1
available databases (e	1
treatment outcome of symptomatic individuals with gamt deficiency	1
in 18% of individuals seizures were eliminated	1
in 49% seizure frequency decreased	1
improvement was seen in 60% of individuals	1
treatment outcome of asymptomatic individuals with gamt deficiency	1
agat deficiency	1
treatment outcome of symptomatic individuals with agat deficiency	1
treatment outcome of asymptomatic individuals with agat deficiency	1
crtr deficiency	1
the goal of treatment is to replenish cerebral creatine levels	1
treatment has included:	1
glycine 150 mg/kg bw/day in 3 doses	1
treatment outcome of individuals with crtr deficiency	1
spectacles or contact lenses for correction of refractive errors	1
management of strabismus	1
penetrating keratoplasty	1
most grafts remain clear after penetrating keratoplasty	1
see acmg-act sheet, acmg algorithm	1
acute management of hyperammonemia	1
rapidly decreasing plasma ammonia concentration	1
scavenger therapy should be continued while dialysis is being performed	1
note: exchange transfusions have no place in hyperammonemic treatment	1
0-1	1
control of intracranial pressure	1
cerebral edema and ischemia may be documented by mri	1
chronic management	1
protein restriction	1
nitrogen scavenger therapy	1
as children grow, doses change to 9	1
9-13 g/m2/day of sodium phenylbutyrate and 8	1
8-15	1
4 g/m2/day of arginine	1
the initial dosage for phenylbutyrate-naïve patients is 4	1
5-11	1
2 ml/m2/day (5-12	1
4 g/m2/day)	1
living related-donor liver transplantation	1
renal fanconi syndrome	1
phosphate replacement to prevent and treat rickets	1
renal glomerular disease	1
renal transplantation	1
73 m2 and azotemia and hypertension rapidly progress	1
symptoms often determine the exact time of transplantation	1
retinal involvement is irreversible	1
nutrition must be adequate for growth	1
oral l-thyroxine replacement for hypothyroidism	1
insulin for diabetes mellitus	1
speech therapy and physical therapy	1
standard treatment for benign intracranial hypertension	1
other central nervous system complications are irreversible	1
chenodeoxycholic acid (cdca)	1
normalization of nerve conduction velocities and subsequent stabilization	1
cdca treatment may be more useful when started early	1
luyckx et al 2014]	1
coenzyme q10 (coq10) treatment may improve muscle weakness	1
repair of inguinal hernia(s)	1
routine management of hip dislocation	1
routine management of refractive errors	1
antiepileptic drugs (aeds): valproate	1
or a combination of aeds can be used	1
psychological help as needed for self-image issues	1
recommended drugs are nadolol (1-2	1
flecainide	1
however, urinary ne excretion exceeds normal levels	1
fludrocortisone, at dosages of 0	1
ptosis can be corrected by surgery	1
sinus problems should be treated as needed	1
dilated cardiomyopathy	1
mean lvef increased from 36% to 53%	1
measurement of reduced sphericity indicated improved ventricular geometry	1
scoliosis treatment as needed is appropriate	1
corticosteroid therapy	1
prednisone	1
75 mg/kg/day or 1	1
5 and 0	1
6 mg/kg/day [fenichel et al 1991]	1
follow-up studies showed that a dose of 0	1
3 mg/kg/day [fenichel et al 1991]	1
35 mg/kg/day) in both dmd and bmd	1
4 mg/kg/day	1
at lower doses of 0	1
alternate-day dosing and intermittent dosing (e	1
side effects did not negatively affect quality of life	1
initiation and length of treatment	1
75 mg/kg/day, prednisone 0	1
published guidelines	1
the optimal maintenance dose of prednisone (0	1
3 mg/kg/day	1
5 mg/kg/day	1
3 mg/kg/day after three to four months	1
deflazacort (0	1
bmd	1
elements of the guidelines include the following:	1
consider therapy based on cardiac phenotype (i	1
, dcm or arrhythmia)	1
cardiac conduction system disease and arrhythmias	1
, atrial or atrioventricular node ablations)	1
lmna-related dcm	1
symptomatic dcm represents late disease	1
individuals with idiopathic or familial dilated cardiomyopathy should:	1
epileptic seizures require antiepileptic drugs (aeds)	1
special adaptive chairs or positioners may be required	1
educational	1
spectacle correction is appropriate where indicated	1
manifestations of the 16p11	1
early diagnosis and provision of therapies facilitate the best outcome	1
referral to other appropriate medical specialists (sue	1
neurodevelopmental disabilities including asd	1
obesity and overweight	1
maintain an active lifestyle	1
chiari i malformation or syringomyelia	1
the spasms are responsive to acth	1
special feeding techniques or devices, e	1
structural anomalies (e	1
hypothyroidism is treated in a standard manner	1
no guidelines have been established for treatment of dent disease	1
thiazide diuretics in doses greater than 0	1
however, their effectiveness has not been clear	1
the response to antiepileptic drugs (aeds) is variable	1
routine ophthalmologic management of strabismus, if present	1
routine correction of refractive error	1
see hereditary deafness and hearing loss overview for details	1
hearing habilitation	1
for those with nonsyndromic bilateral congenital hearing loss	1
hearing aids should be fitted as soon as possible	1
educational programs designed for individuals with hearing impairment are appropriate	1
see deafness and hereditary hearing loss overview	1
management of neurologic manifestations in neonatal multisystem disease	1
hypotonia may be significant	1
the one-year survival rate was 64%	1
five of the 14 survived longer than five years	1
corticosteroid administration	1
corticosteroids may be slowly tapered to the minimal effective dose	1
the recommended maximum maintenance dose is ≤0	1
red blood cell transfusion	1
7% ±10	1
1% ±11	1
survival was the best (92	1
cancer treatment	1
treatment of malignancies should be coordinated by an oncologist	1
, for clubfeet)	1
comprehensive coordinated care among specialties is required	1
bone marrow failure (bmf)	1
, aggression, mood swings)	1
the suggested starting dose of oxymetholone is 0	1
hematopoietic growth factors may be useful in bmf	1
this risk has not been quantitated	1
studies are ongoing	1
dld pathogenic variants cause variable deficiency in three enzymatic pathways	1
branched chain alpha-ketoacid dehydrogenase (bckdh) complex	1
α-ketoglutarate dehydrogenase (αkgdh) complex	1
pyruvate dehydrogenase (pdh) complex	1
early-onset neurologic presentation	1
review of treatment strategies	1
protein/bcaa-restriction	1
ketogenic/high-fat diet	1
five had no clinical or biochemical benefit	1
two improved clinically	1
carbohydrate tolerance	1
dichloroacetate (dca)	1
additional therapies used with limited success include:	1
coenzyme q10	1
lipoic acid	1
biotin	1
empiric recommendations	1
for acute management (based on the above review)	1
this is typically achieved by the following:	1
promotion of an anabolic state:	1
maintain serum glucose concentration in the normal range	1
protein should then be reintroduced gradually	1
hepatic presentation	1
correction of metabolic acidosis with sodium bicarbonate	1
correction of any coagulopathy with fresh frozen plasma	1
avoidance of liver-toxic medications	1
episodes of catabolic stress (e	1
caution:	1
high doses are usually required (0	1
4-1	1
0 mg/kg/day of glibenclamide)	1
transfer protocols are available at www	1
diabetesgenes	1
org	1
high caloric intake should be maintained to achieve weight gain	1
insulin can be discontinued when blood glucose concentrations stabilize	1
, some residual endogenous insulin remains)	1
note: macroglossia could potentially cause airway obstruction	1
currently no effective treatment exists for any type of hsan	1
provision of corrective lenses for myopia	1
treatment of retinal detachments or glaucoma	1
antiepileptic drugs for seizures	1
children	1
adults	1
gradual increase to higher doses is recommended	1
for affected children, adaptation of educational programming to abilities	1
duane anomaly	1
severe strabismus may require eye surgery	1
radial ray malformations	1
hearing deficits	1
hearing aids may be required	1
nonsurgical treatment of ophthalmologic findings	1
surgical treatment of ophthalmologic findings (extraocular muscle surgery)	1
to correct or improve compensatory head posture	1
to improve upshoot or downshoot	1
principles of surgical approach as reviewed in	1
kekunnaya et al [2015]	1
type 1 and type 3	1
type 2	1
approach for non-treatment	1
approach for treatment	1
the galactose challenge	1
for example:	1
, after the introduction of solid foods)	1
supportive care may include the following:	1
occupational and physical therapy	1
alternative and augmentative communication	1
behavioral therapy (e	1
, applied behavioral analysis therapy)	1
psychotropic medications for behavioral manifestations	1
many of these are preventable	1
seizures should be managed by a neurologist using standard practice	1
childhood apraxia of speech	1
anxiety/selective mutism	1
autism spectrum disorder (asd)	1
attention deficit hyperactivity disorder (adhd)	1
aggression	1
applied behavior analysis intervention is recommended	1
oppositionality	1
specific medical problems are treated in the following ways:	1
hydrocephalus as needed with ventriculo-peritoneal shunting	1
aortic dilation with beta blocker therapy in some affected individuals	1
strabismus in the usual manner	1
recurrent otitis media in the usual manner	1
poor feeding in infants	1
human growth hormone replacement therapy	1
club feet	1
casting	1
educational program should be tailored to individual needs	1
educational programs to address the specific needs identified	1
speech therapy directed at improving communication skills	1
therapeutic management of sleep disturbances if necessary	1
early intervention with occupational therapy for feeding problems	1
consideration of tube feeding for severe persisting feeding problems	1
anticholinergics (e	1
, trihexyphenidyl)	1
if medications fail	1
, prior to sufficient medication trials)	1
acetazolamide	1
sulthiame 50-200 mg daily may reduce the attack rate	1
this medication is generally well tolerated	1
surgical intervention is required to correct pyloric atresia	1
many children need medical treatment for gastroesophageal reflux disease	1
primary layers may include any the following:	1
ordinary band-aids®	1
non-stick products (e	1
, telfa® or n-terface®)	1
, mepitel® or mepilex®)	1
other nutritional deficiencies must also be addressed:	1
calcium and vitamin d supplementation for osteopenia and osteoporosis	1
selenium and carnitine replacement to help prevent dilated cardiomyopathy	1
zinc replacement to enhance wound healing	1
occupational therapy may be helpful in preventing progressive hand contractures	1
psychosocial support including social services and psychological counseling is essential	1
ordinaryband-aids®	1
the most common secondary complication is infection	1
both antibiotics and antiseptics need to be employed	1
dressings usually involve three layers:	1
some individuals with ebs can use ordinary bandages	1
foam dressings and/or rolls of gauze (e	1
, one-layer) dressing	1
dystrophic nails	1
in many cases, wigs are helpful	1
palmoplantar hyperkeratosis	1
skin emollients may help relieve palmoplantar hyperkeratosis	1
however, pain can be difficult to control	1
career counseling is recommended	1
deep stitches should be applied generously	1
anti-inflammatory drugs may help with joint pain	1
cardiovascular problems should be treated in a standard manner	1
modalities must be tailored to the individual	1
assistive devices	1
braces are useful to improve joint stability	1
pain medication	1
adjustments may be necessary for other populations	1
nsaids (nonsteroidal anti-inflammatory drugs) (e	1
cox-2 inhibitors (e	1
they are also sometimes helpful in treating neuropathic pain	1
all require gradual titration before reaching therapeutic levels	1
topiramate and lamotrigine have also been used successfully	1
nausea is the most common side effect	1
routine use of benzodiazepines is not recommended	1
medication precautions	1
abrupt cessation of anti-seizure medications can precipitate a seizure	1
when discontinuing, they should be tapered gradually	1
severity can range from mild to life threatening	1
surgery and other procedures	1
anesthetic nerve blocks can provide temporary relief of neuropathic pain	1
bone density	1
for severe bleeding (e	1
other treatable causes, such as h	1
pylori infection, should be investigated	1
rarely, severe enlargement (>4	1
5-5	1
0 cm) requires surgical evaluation	1
periodontal disease should be identified and treated	1
temporomandibular joint laxity and dysfunction are difficult to treat	1
there are no specific interventions of proven benefit	1
intra-oral devices are sometimes helpful	1
psychiatric	1
antidepressants are also of great benefit	1
consumer support groups are available and can be very beneficial	1
, the uterus in pregnancy)	1
bracing may be required to support unstable joints	1
swimming is recommended	1
vascular surgery is fraught with danger	1
antispastic medications	1
muscle relaxants	1
contractures	1
severe diarrhea	1
maintain hydration & caloric intake	1
tube feeding often necessary	1
poor energy metabolism & oxidative stress	1
, contractures)	1
, feeding, grooming, dressing, writing)	1
routine repair is appropriate	1
pulmonary emphysema is treated symptomatically	1
no definitive treatment is available	1
based on experience in other related disorders (e	1
aortic aneurysm replacement has been performed successfully	1
joint hypermobility can be supported by muscle reinforcing physical therapy	1
standard management of gastroesophageal reflux	1
standard interventions for:	1
cardiac defects	1
hip dysplasia and other skeletal complications	1
cryptorchidism and/or micropenis	1
refractive errors, strabismus, or other ophthalmologic issues	1
seizures, if present	1
then 1 mg 1x daily thereafter)	1
prevnar-13® and h	1
the incidence of post-splenectomy sepsis varies among studies	1
cholecystectomy	1
valproic acid is the first drug of choice	1
it diminishes myoclonus and the frequency of generalized seizures	1
the phototoxic pain is not responsive to narcotic analgesics	1
tanning products	1
β-carotene	1
hepatic complications may be accompanied by motor neuropathy	1
the pain is not responsive to narcotic analgesics	1
sun creams containing a physical reflecting agent (e	1
reports on treatments in a series involve heterogeneous populations	1
cooling the extremities reduces pain in a symptomatic person	1
01) [mork et al 2004]	1
experts have reported typically mild to moderate pain relief	1
remissions (i	1
carbamazepine	1
oxcarbazepine use in treating em has not been reported	1
topical application of 1	1
0% amitriptyline hydrochloride and 0	1
calcium antagonists	1
magnesium	1
cyclosporine was successful in one person with erythromelalgia	1
sympathetic block, surgical sympathectomy, and epidural infusion	1
the main problems to manage are:	1
adaptation of education to the level of cognitive handicap	1
epilepsy, which is amendable to standard treatments	1
osteochondromas require no therapy in the absence of clinical problems	1
leg-length inequalities greater than 2	1
surgical resection is the treatment for sarcomatous degeneration	1
3% (±5	1
9%) [mehta et al 2017]	1
mds/aml treatment remains challenging	1
solid tumors	1
acroparesthesia	1
diphenylhydantoin	1
a potential side effect of diphenylhydantoin is gingival hypertrophy	1
carbamazepine has similar effects	1
chronic hemodialysis and/or renal transplantation have become lifesaving procedures	1
therefore, successful renal transplantation corrects renal function	1
thrombosis	1
5 (therapeutic range 2	1
colonic polyps	1
types of colectomy include the following:	1
total colectomy with ileorectal anastomosis (ira)	1
this is a single-stage procedure	1
total proctocolectomy with permanent ileostomy	1
the choice of procedure depends on the clinical circumstances	1
small-bowel polyps	1
osteomas may be removed for cosmetic reasons	1
desmoid tumors	1
adrenal tumors	1
chemoprevention	1
nsaids	1
appropriate treatment for:	1
inguinal hernias	1
routine repair	1
cutis laxa	1
pulmonary emphysema	1
no treatment available	1
no definite treatment is available to date	1
inadequate nutrition	1
standard treatment w/antiepileptic drugs	1
immobility/wheelchair dependence	1
, wheelchair	1
cardiomyopathy and arrhythmia	1
standard treatment per cardiology recommendations	1
consider granulocyte colony stimulating factor 2	1
significant acidosis	1
consider bicarbonate therapy	1
cataract and/or strabismus	1
surgical treatment if indicated	1
hearing aids	1
there is no definite treatment for fcmd	1
monitoring for orthopedic complications such as foot deformity and scoliosis	1
prompt treatment of acute respiratory tract infections	1
antiepileptic drugs (aeds) when indicated	1
surgical treatment for gastroesophageal reflux when indicated	1
gastrostomy when indicated to assure adequate caloric intake	1
routine therapy of cardiomyopathy	1
feeding problems	1
maintain adequate nutrition and avoid aspiration	1
gastroesophageal reflux	1
orthostatic hypotension	1
counter-maneuvers (e	1
squatting had the greatest effect	1
kidney and bladder	1
bradyarrhythmia	1
soft contact lenses can promote corneal healing	1
corneal transplantation has had limited success	1
spinal fusion may be necessary	1
many adults use walkers or wheelchairs when outside the home	1
sialorrhea is a common	1
surgical treatment of gastrointestinal atresia when present	1
follow up and treatment of possible cardiac and renal anomalies	1
treatment for significant hearing loss	1
developmental or educational intervention for children with learning difficulties	1
retinal avascularity per se often requires no treatment	1
individualized management of behavior problems	1
neurologic management of seizures	1
standard management of chronic constipation for individuals with fgs1	1
communication rehabilitation with sign languages or alternative means of communication	1
standard treatment for any of the following if identified:	1
refractive errors and strabismus	1
orthopedic complications	1
investigation for celiac disease if indicated by clinical features	1
cervical spine instability	1
large joint dislocations	1
scoliosis is treated medically	1
no effective surgical intervention has been described	1
club feet are managed in a routine manner	1
febrile and inflammatory episodes are usually treated with nsaids	1
papillomatosis	1
camptodactyly often improves with physical and occupational therapy	1
consultation with:	1
folate formulations	1
leucovorin is available in oral and parenteral formulations	1
neither drug is available for parenteral administration	1
deplin® is available as a 15-mg tablet	1
folate dosing	1
with intramuscular injections of approximately 1	1
speech and language deficits	1
no single recommended treatment exists	1
dysarthria [pennington et al 2009]	1
language deficits [law et al 2003]	1
literacy impairments [snowling & hulme 2012]	1
cognitive deficits	1
fine and gross motor deficits	1
fragile x syndrome	1
therapy must be individualized and closely monitored	1
fxtas	1
poi	1
there is little objective evidence regarding management of frda	1
speech therapy to maximize communication skills	1
treatment of sleep apnea by continuous positive airway pressure	1
measures include the following:	1
in fryns syndrome, additional anomalies may dictate further consultations	1
see also congenital diaphragmatic hernia overview	1
physical therapy and rehabilitation	1
consultation with a physical therapist is indicated	1
exercise in fshd	1
ophthalmologic disease	1
orthopedic intervention	1
there is no consensus treatment guideline for ftd3	1
individuals with seizures are treated with antiepileptic drugs	1
nutritional intervention (e	1
wheelchairs can be useful for some individuals	1
5x109/l can vary greatly among patients	1
fevers and infections require prompt treatment with antibiotics	1
treatment of arterial calcification	1
bisphosphonate therapy	1
026, log-rank test)	1
the dose of pamidronate has varied from 0	1
cardiovascular treatment	1
anti-hypertensive therapy	1
017-0	1
068 μg/kg/min [ciana et al 1997]	1
prevention of coronary thrombosis	1
treatment of hearing loss	1
generalized epimerase deficiency galactosemia	1
, some fruits and vegetables, organ meats)	1
, hepatic cirrhosis or mature cataracts)	1
peripheral epimerase deficiency galactosemia	1
intermediate epimerase deficiency galactosemia	1
however, insufficient data exist to make firm recommendations	1
appropriate ophthalmologic treatment (e	1
individuals with gata1-related cytopenia are treated supportively	1
transfusion of blood products for severe anemia and bleeding	1
analgesics for bone pain	1
, improved joint range of motion)	1
supplemental treatment	1
care is best provided by a physician (e	1
clobazam (0	1
topiramate [coppola et al 2002]	1
ethosuximide	1
can be effective for absence seizures	1
levetiracetam (20-80 mg/kg/day)	1
potassium bromide	1
phenobarbital	1
sleep deprivation and illness can exacerbate scn1a-related seizures	1
routine seizure and personal safety counseling is indicated	1
seizures are not always responsive to conventional aeds	1
ethosuximide and high-dose piracetam for myoclonic seizures	1
placement of an indwelling venous access device	1
creating a portable microenvironment	1
having a written emergency department protocol	1
establishing emergency routines for the family	1
creating personal time to decrease parent stress	1
finding respite care	1
contacting an internet support group	1
joint manifestations: regular physiotherapy to prevent joint limitation	1
heart: valve replacement	1
tracheal stenosis: tracheostomy when severe	1
surgical treatment	1
pcg is almost always managed surgically	1
beta-blockers (e	1
, timolol), parasympathomimetics (e	1
, pilocarpine), sympathomimetics (e	1
treatment of refractive errors	1
affected individuals develop a mild compensated metabolic acidosis when ketotic	1
phenobarbital and valproic acid can inhibit glut1 transport	1
valproic acid may partially inhibit beta-oxidation of fatty acids	1
these agents also can cause kidney stones	1
response has been modest at best	1
gm1 gangliosidosis	1
maintenance of adequate hydration and adequate calories for growth	1
aggressive seizure control	1
medical management of cardiac involvement	1
mps ivb	1
the general concepts of care include the following	1
sex assignment	1
all individuals should receive a sex of rearing	1
surgical intervention should focus on functionality	1
removal of müllerian remnants may be considered	1
management of gonads	1
hormone therapy	1
if an individual is given a male sex assignment:	1
5 standard deviations below the mean for age)	1
testosterone therapy is typically required to initiate and sustain puberty	1
if an individual is given a female sex assignment:	1
estrogen therapy is used to initiate breast development and puberty	1
psychosocial aspects of care	1
” [lee et al 2006]	1
later, educational and behavioral therapy are often warranted	1
oral-motor therapy to alleviate chewing and swallowing problems	1
routine protocols to alleviate sleep apnea	1
tympanostomy tube placement for recurrent ear infections	1
surgical removal of ingrown toenails to prevent infection	1
walkers or other assistive walking devices	1
intravenous fluids to prevent dehydration in individuals with recurrent vomiting	1
surgical bone lengthening may be an option for some	1
adaptive aids for people with short stature are appropriate	1
speech/language deficits	1
metabolic specialist familiar with the multisystem nature of gsdi	1
medical nutrition therapy goals	1
maintain	1
normal glucose levels and prevent hypoglycemia:	1
frequent daytime feedings	1
note: recommendations for uncooked cornstarch dosing are: 1	1
provide	1
optimal nutrition for growth and development:	1
, protein low in fat)	1
treatment of other manifestations	1
sodium levels should also be monitored	1
kidney transplantation can be performed for esrd	1
liver transplantation can be considered when other interventions have failed	1
g-csf should be administered subcutaneously starting at 1	1
0 μg/kg given daily or every other day	1
0 x 109/l is reached	1
arteriopathy	1
conduction disturbances	1
muscle weakness	1
nutrition/feeding	1
respiratory insufficiency	1
respiratory support including cpap and bipap may be required	1
special formulas are not required	1
3 mmol/l)	1
emergency protocol	1
5 normal saline administered at 1	1
hepatic manifestations	1
selecting appropriate candidates for liver transplantation can be complex	1
aerobic training (on a regular diet)	1
95% confidence intervals 20	1
3 to 2496	1
7) after controlling for age	1
7 metabolic equivalents (mets, with 1met equaling 3	1
5 ml o2/kg/min) necessary for independent living	1
5mets higher than in those who were not active	1
avoid a totally sedentary life, which induces deconditioning	1
pharmacologic and nutritional treatments	1
the authors' conclusions:	1
this treatment does not influence sustained or unexpected exercise	1
a carbohydrate-rich diet was of benefit	1
pharmacologic treatments	1
nutritional treatments	1
liver phk deficiency	1
hypoglycemia	1
the dose of cornstarch can range from 0	1
6 to 2	1
5 g/kg every six hours based on clinical symptoms	1
for signs of	1
muscle phk deficiency	1
surgery may be required	1
hypothalamic involvement	1
central diabetes insipidus may require treatment with desmopressin	1
temperature dysregulation can be managed by modifying the environment	1
surgery of hand and foot defects can improve dexterity	1
tethered cord may require surgical intervention	1
some children may require a gastrostomy and/or tracheostomy	1
acute attacks	1
in an individual presenting with acute abdominal symptoms:	1
discontinue all nonessential medications	1
provide glucose-containing iv solution to reverse the fasting state	1
treat seizures with a short-acting benzodiazepine (e	1
not yet approved in the us)	1
some individuals recover with a glucose infusion only	1
200 mg once daily is appropriate for most individuals	1
the following responses to hematin infusion can be expected:	1
chronic (cutaneous) manifestations	1
grey or smoke colored filters provide only partial protection	1
pharmacologic agents may suppress abnormal movements	1
tremor in one individual was suppressed with clonazepam	1
no specific therapy is currently available for alsp	1
other:	1
treatment should be coordinated through a hemophilia treatment center	1
(individuals in the usa see national hemophilia foundation	1
immunizations should be administered preferably subcutaneously	1
ddavp®	1
(desmopressin acetate)	1
immune tolerance therapy	1
elsewhere worldwide: see world federation of hæmophilia)	1
immunizations should be administered subcutaneously	1
inhibitors	1
clinical	1
biochemical	1
non-expressing p	1
cys282tyr homozygotes	1
variceal bleeding	1
transjugular intrahepatic portosystemic shunts (tips) are widely available	1
hypersplenism	1
hypersplenism usually does not result in clinically significant sequelae	1
abnormalities of the biliary tree	1
cholangitis is best treated with rapid institution of appropriate antibiotics	1
biliary stones	1
cholangiocarcinoma and hepatocellular carcinoma	1
these should be managed by a multidisciplinary team	1
patient education	1
urologic referral is indicated	1
gynecologic referral is indicated	1
hymenectomy may be necessary for tight constriction ring	1
however, no data on its use are available	1
lymphedema management (manual lymphatic drainage, compression)	1
muscle	1
physical therapy and exercise to promote mobility and prevent contractures	1
lung	1
noninvasive ventilation if needed	1
pancreas	1
treatment of pancreatic exocrine insufficiency with pancreatic enzyme supplementation	1
treatment of cholestasis with ursodeoxycholic acid	1
enteral feeding as needed	1
surgical removal of visually significant cataracts	1
the primary curative treatment of gastric cancer is surgical resection	1
frequent small meals tend to maximize caloric intake	1
stiffened peripheral vasculature may be less tolerant to dehydration	1
therefore maintaining optimal hydration orally is recommended	1
infections are generally handled as for unaffected children	1
anesthetics should be used with particular caution	1
nitroglycerin is frequently of benefit if angina develops	1
statins are recommended for their putative effect on farnesylation inhibition	1
injuries	1
wound healing is normal	1
fracture rate is equivalent to the general pediatric population	1
hips	1
teeth	1
, finger) joints	1
eye care	1
hearing aids can be used, when clinically necessary	1
treatment of acute hyperammonemic episodes	1
, as part of nitrogen scavenging therapy)	1
this approach also stops all protein intake	1
infusion 1	1
infants and children	1
adolescents and adults	1
10% arginine hcl	1
210 mg/kg/day	1
drug	1
action	1
glucose	1
arginine 1	1
sodium benzoate 3	1
sodium phenylacetate 3	1
hemodialysis	1
dialysis may be prolonged if the catabolic state persists	1
note: non-essential amino acids (i	1
nosebleeds	1
oral drug therapy	1
topical drug therapy	1
, timolol 0	1
gastrointestinal bleeding	1
pulmonary avms	1
hepatic avms	1
cerebral avms	1
cerebral avms greater than 1	1
intestinal polyps	1
most investigators recommend maintaining all glucose levels above 3	1
somatostatin analogs (e	1
glucagon, which increases hepatic gluconeogenesis, helps prevents hypoglycemia	1
however, therapeutic success has not been confirmed	1
dietary intervention:	1
night-time continuous gastric drip containing glucose or glucose polymer	1
in such individuals, surgery must be considered	1
if structural damage to the lungs (e	1
, pseudomonas) or fungi (e	1
, aspergillus)	1
adequate skin lubrication is needed with frequent bleach baths	1
hlh-1994	1
hlh-2004	1
in general, treatment involves the following:	1
after achievement of clinical remission in simplex cases (i	1
, a single occurrence in a family)	1
cutaneous lesions	1
cutaneous leiomyomas should be examined by a dermatologist	1
treatment of cutaneous leiomyomas is difficult:	1
surgical excision may be performed for a solitary painful lesion	1
lesions can be treated by cryoablation and/or lasers	1
uterine fibroids should be evaluated by a gynecologist	1
hysterectomy should be performed only when necessary	1
renal tumors	1
early detection of kidney tumor in hlrcc is important	1
chelation therapy with disodium calcium edetate	1
short term	1
, >3 hours)	1
long term	1
chelation therapy should be continued lifelong	1
iron therapy	1
iron is a competitive inhibitor of intestinal manganese uptake	1
dystonia can result in physical deformities and pain	1
at present no disease-modifying therapy exists	1
pain management is the primary goal of therapy:	1
cleft palate is best managed by a local craniofacial team	1
management of colon cancer in a person with lynch syndrome	1
complications should be managed appropriately (e	1
multidisciplinary management at various ages may include:	1
endocrinology to optimize bone homeostasis and avoid exacerbating treatments	1
nephrology to monitor calcium homeostasis and examine for nephrocalcinosis	1
neurology to prophylactically or prospectively treat seizures and manage myopathy	1
neurosurgery or craniofacial team to manage pseudocraniosynostosis	1
orthopedics to manage primary and secondary skeletal manifestations	1
pain management	1
pediatric and adult dentistry to manage tooth loss	1
enzyme replacement therapy	1
perinatal/infantile hpp study outcomes	1
survival	1
bone findings	1
juvenile-onset hpp study outcomes	1
age at treatment onset was six to 12 years	1
perinatal types	1
infantile type	1
in the absence of ert, supportive management remains	1
calcium homeostasis	1
craniosynostosis in those with the infantile phenotype is variable	1
childhood (juvenile) and adult hypophosphatasia	1
osteoarthritis may respond to nsaids	1
pseudofractures and stress fractures are difficult to manage	1
early surgical repair may improve feeding	1
the principles of treatment are summarized in table 7	1
goal	1
means	1
practical details	1
to avoid triggering or aggravating factors for paralytic attacks	1
avoid:	1
strenuous effortprolonged immobilitycarbohydrate-rich diet	1
treatment of paralytic attack:	1
shorten/prevent aggravation of the weakness episodenormalize kalemia	1
preventive treatment for paralytic attacks	1
daily k+ supplementation	1
slow-release forms of potassium may be used	1
diamox (acetazolamide)	1
k+-sparing diuretics	1
preventive treatment for late-onset myopathy	1
diamox (acetazolamide)?	1
medical precautions	1
other elements of management	1
strenuous effort	1
prolonged immobility	1
carbohydrate-rich diet	1
provide dietary review/counseling	1
shorten/prevent aggravation of the weakness episode	1
normalize kalemia	1
avoid glucose intake	1
do not use slow-release forms of potassium	1
oral potassium: initially, 1 meq/kg	1
3 meq/kg after 30 minutes if no improvement	1
iv potassium: 0	1
avoid corticosteroids if possible	1
kinesitherapy in case of permanent pelvic deficit	1
paralytic crisis	1
mild to moderate paralytic episodes	1
aqueous potassium contained in vials may act more rapidly	1
, 4	1
3 meq/kg can be administered (20 meq	1
, 1	1
severe paralytic episodes	1
note the following critical points:	1
3 meq/kg/h of potassium (i	1
some individuals exhibit serious arrhythmias with only mild hypokalemia	1
they are associated with a risk for cardiac arrest	1
attempting to abort paralytic attacks when they begin	1
correction of these refractive errors can improve visual acuity	1
the surgery is not always successful	1
humidifiers may reduce the frequency of nosebleeds	1
oral contraceptives can limit the duration of menstrual periods	1
the authors know of several additional successful lung transplantations	1
primary hyperparathyroidism	1
minimally invasive parathyroidectomy requires the use of:	1
preoperative imaging (e	1
jaw tumors	1
uterine tumors	1
a diabetic clinic is a good source of advice	1
appropriate shoes and socks are recommended	1
it is best to prevent callous formation in neuropathic skin	1
hyperthermia or hypothermia	1
hypothermia responds to warming by a blanket as necessary	1
of note, longstanding infections require wide surgical debridement	1
bone and joint deformities can be managed by corrective osteotomy	1
joint dislocations are best treated conservatively	1
the oral self-mutilation (i	1
6-0	1
see warren & nade [1999]	1
charcot joints may require arthrodesis	1
opiates are contraindicated as hsn1a is a chronic disorder	1
current recommendations:	1
commonly required interventions include the following:	1
shunting for hydrocephalus	1
tonsillectomy and adenoidectomy	1
positive pressure ventilation (cpap or tracheostomy)	1
carpal tunnel release	1
cardiac valve replacement	1
inguinal hernia repair	1
hip replacement	1
developmental, occupational, and physical therapy are often necessary	1
for further information about eculizumab, click here	1
typically, plasma exchange is undertaken daily initially	1
cfb	1
cfh autoantibodies	1
cfi	1
, persistent severe thrombocytopenia and hemolytic anemia)	1
molecular genetic testing can help to define graft prognosis	1
c3, cfb, and cfi	1
four individuals with isolated	1
importantly, there were no ahus recurrences after transplantation	1
beta blockers	1
l-type calcium channel blockers	1
note: direct vasodilators (e	1
dose is based on response to therapy	1
gout typically responds well to prednisone or colchicine	1
prednisone is the preferable alternative	1
fludrocortisone treatment (0	1
mineralocorticoid replacement	1
kidney transplantation cures adtkd-ren	1
treatment for hyperpp is symptomatic and not curative	1
, 2 g glucose per kg body weight)	1
1 mg salbutamol	1
calcium gluconate (0	1
adults with fh	1
risk factors (e	1
4 mmol/l])	1
risk factors:	1
clinically evident cad or other atherosclerotic cardiovascular disease	1
8 mmol/l)	1
diabetes mellitus or metabolic syndrome	1
women age <55 years)	1
current smoking	1
3 mmol/l] using an isoform insensitive assay)	1
class	1
ldl-lowering response	1
statins	1
↑ ldlr activity (1o)	1
>35% 1, 2	1
cholesterol absorption inhibitors (ezetimibe)	1
mipomersen (apob antisense) 4	1
blocks apob production in the liver	1
mtp inhibitor(lomitapide) 4	1
pcsk9 inhibitors(alirocumab, evolocumab)	1
↓ ldl-receptor degradation	1
50% 6	1
bile acid sequestrants(cholestyramine, colesevelam)	1
stanol esters	1
10% 1, 3	1
children with fh	1
9 mmol/l)	1
consultation or referral to a lipid specialist is recommended	1
statins are the preferred initial pharmacologic treatment in children	1
4 mmol/l)	1
children and adults with homozygous fh (hofh)	1
nla guidelines for homozygous fh (full text):	1
referral to a lipid specialist is indicated	1
early initiation of therapy and monitoring are recommended	1
multiple drug therapy is usually needed	1
many states do not have an apheresis center	1
in adults the initial dose is 0	1
5 mg twice a day	1
the dose can be increased up to 2	1
0 mg three times a day	1
antiepileptic drugs if epileptic seizures are present	1
the usual neurosurgical approach to spinal stenosis is laminectomy	1
the l2-3 level most commonly required decompression	1
seizure disorders should be treated in the standard manner	1
management of blisters in a standard manner (i	1
, not opening them, avoiding trauma)	1
topical treatment (e	1
, medications, oatmeal baths) to relieve discomfort	1
significant skin involvement may benefit from dermatology management	1
treatment of infections as for any other cellulitis	1
standard treatment for retinal detachment	1
physical and occupational therapy to promote mobility and independence	1
aids for mobility and limb function	1
treatment is symptomatic only:	1
management should be tailored to the individual	1
paget disease of bone	1
actonel®/risedronate	1
fosamax®/alendronate	1
aredia®/pamidronate	1
tnfα antagonists have also been used	1
growth hormone (gh) therapy	1
treatment by a psychiatrist for neuropsychiatric symptoms is indicated	1
dopamine agonist therapy has been tried in some cases	1
monitor fluid intake to assure adequate intravascular volume	1
appropriate medications for management of seizures and spasticity	1
chest physiotherapy to prevent respiratory complications	1
sleep studies to assess nocturnal hypoventilation and institute appropriate interventions	1
assessment for scoliosis	1
dietary	1
medical	1
management focuses on rehabilitation to optimize mobility and communication	1
treatment of seizures follows standard management principles	1
treatment of iron overload	1
it is simple, safe, and effective	1
the hematocrit should be monitored prior to phlebotomy	1
usually four to six phlebotomies annually are sufficient	1
treatment of secondary complications	1
transdermal preparations (i	1
arthropathy is not modified by treatment	1
cirrhosis is thought to be irreversible despite iron removal	1
diabetes mellitus may require insulin administration	1
cardiac issues	1
even with additional therapies (e	1
qtc interval >550 msec	1
syncope before age five years	1
left cardiac sympathetic denervation has been effective for some individuals	1
iron deficiency anemia	1
hypotonia and therapeutic interventions	1
periodic neuropsychologic and developmental testing at appropriate ages	1
other cns malformations	1
posterior fossa cysts and fluid collections rarely require intervention	1
encephalocele may require primary surgical closure	1
corrective lenses for refractive errors	1
consultation with a nephrologist is indicated	1
hepatic fibrosis	1
consultation with a gastroenterologist is indicated	1
some individuals have needed orthotopic liver transplantation	1
surgical treatment for polydactyly	1
appropriate medical management by an orthopedic specialist for scoliosis	1
orofacial clefting is treated by standard surgical interventions	1
no specific guidelines are currently available	1
jps	1
jps/hht	1
treat manifestations of hht as needed	1
see hereditary hemorrhagic telangiectasia	1
monitoring for nocturnal lagophthalmos by parents or caregivers is recommended	1
if present, evaluation by an ophthalmologist is indicated	1
skeletal features	1
early referral to physical therapy to help increase joint mobility	1
orchiopexy in males with undescended testes	1
anal anomalies	1
referral to an urologist or nephrologist as indicated	1
facial features	1
hearing aids as needed for hearing loss	1
no specific management guidelines have been developed	1
management is mostly supportive	1
lacrimal duct obstruction	1
tear duct massage	1
consider lacrimal duct stent placement	1
cleft palate, bifid uvula, or velopharyngeal insufficiency	1
management by a cleft/craniofacial team	1
cpap or bipap	1
ent evaluation for tonsillectomy/adenoidectomy	1
pulmonary consultation	1
feeding difficulties or signs of aspiration	1
use of a special nipple or bottle with cleft palate	1
short-term nasogastric feeding tube	1
consideration of gastrostomy tube	1
gastroesophageal reflux disease	1
standard positioning & pharmacologic treatment	1
musculoskeletal findings (i	1
, contractures, scoliosis)	1
ankle-foot orthoses or other assistive devices	1
physical therapy and/or occupational therapy evaluation	1
consultation w/an orthopedist	1
seizure disorder	1
evaluation of blood sugar & electrolytes	1
standard treatment for seizures	1
consider eeg and referral to a neurologist	1
unexplained hypoglycemia or suspected hyperinsulinism	1
consideration of diazoxide therapy	1
consider referral to an endocrinologist	1
consider referral to a neurodevelopmental specialist and/or neuropsychiatric testing	1
benign familial neonatal epilepsy (bfne)	1
all but three had family histories of neonatal seizures	1
pathogenic variants in kcnq3 were present in two	1
earlier initiation of cbz was associated with shorter hospitalization	1
no side effects of cbz were reported	1
8 years)	1
benign familial infantile epilepsy (bfie)	1
no established treatment for kindler syndrome exists	1
standard blister care in childhood	1
antibiotics may be used to treat an infected blister	1
use of moisturizers for dry, pruritic skin	1
mucosal involvement	1
mouth and periodontium	1
gastrointestinal tract	1
esophageal dilatation may be indicated for those with dysphagia	1
anal stenosis and bleeding requires regular laxatives	1
severe colitis may require surgical bowel resection in some cases	1
urethra	1
meatal stenosis may require dilatation	1
strictures may require stenting and/ or surgical intervention	1
phimosis	1
no well-controlled treatment trials have been reported	1
specialized neurologic care for individuals with epilepsy	1
males with igd age ≥18 years	1
hormone replacement therapy for males not desiring fertility	1
doses do vary with newer testosterone preparations	1
if testosterone levels fall, therapy should be reinitiated	1
human chorionic gonadotropin (hcg)	1
male infants/adolescents with suspicion of igd	1
if igd is clinically suspected (e	1
fsh is added at doses ranging from 37	1
5 to 75 iu as either hmg or recombinant formulation	1
pulsatile gnrh stimulation vs	1
females with igd	1
hormone replacement therapy for females not desiring fertility	1
many formulations of estrogens are available	1
a suggested oral regimen is using premarin 0	1
25 mg daily	1
in vitro fertilization	1
the following treatment recommendations are appropriate:	1
educational intervention and speech therapy beginning in infancy	1
cataract and ptosis surgery if indicated	1
hearing aids or cochlear implant if needed	1
cardiac function assessment and treatment if needed	1
orchidopexy in males with undescended testes	1
treatment of vesicoureteral reflux if indicated	1
other facial	1
cleft palate repair if present	1
placement of eyelid slings for severe ptosis	1
cochlear implants and hearing aids for neurosensory hearing loss	1
hormone replacement for endocrinopathies	1
dilation of the upper esophageal sphincter to alleviate cricopharyngeal achalasia	1
replacement of pancreatic enzymes in pearson syndrome	1
treatment of depression	1
ventilatory support for respiratory abnormalities in leigh syndrome	1
surgical treatment should be performed as needed	1
developmental progress should be monitored and stimulated	1
adducted thumbs	1
surgical intervention is not generally indicated	1
a splint may help reduce the degree of adduction	1
neurologic features should be monitored	1
follow up and treatment is nonspecific	1
autonomic dysfunction	1
neurogenic bladder:	1
urinary urgency may require spasmolytics (e	1
, solifenacine succinate)	1
, docusate) or a laxative is needed	1
sexual dysfunction can be alleviated with sildenafil	1
anhidrosis is managed by avoiding overheating	1
cognitive dysfunction can affect social interactions and financial management	1
valproic acid is the traditional antiepileptic treatment for ld	1
wolman disease	1
malabsorption and malnutrition	1
hepatomegaly and liver disease	1
adrenal cortical insufficiency	1
consider discussion of comfort care options	1
cesd	1
lipophilic vitamin supplementation may also be beneficial	1
the following as needed:	1
recurrence is possible even with more definitive treatment	1
surgery for ptosis if clinically indicated (e	1
, obscured vision, cosmetic appearance)	1
individualized education plans for learning disorders and school performance issues	1
biotin-thiamine-responsive basal ganglia disease	1
biotinidase deficiency	1
(btd)	1
coenzyme q10 biosynthesis deficiency	1
(pdss2)	1
early intervention with special education maximizes cognitive development	1
referral to services for the visually impaired is recommended	1
treatment of hearing loss may include the following:	1
extrapyramidal manifestations	1
dystonia and dyskinesias may cause significant disability	1
pharmacologic treatment may result in significant functional improvement	1
cognitive developmental delay/encephalopathy	1
augmentative communication may be used to address speech deficits	1
referral to a cardiologist for standard supportive treatment of cardiomyopathy	1
clinical genetics consultation	1
avoidance of prolonged immobility is recommended	1
there is no curative therapy for lp	1
treatments of unproven efficacy	1
click here (pdf) for further details	1
specific treatment for lms does not currently exist	1
lateral spinal meningoceles	1
symptomatic treatment of neurologic sequelae (e	1
physiotherapy to reduce risk for joint subluxation and dislocation	1
routine management of the following:	1
congenital cardiac defects	1
hyperuricemia	1
allopurinol therapy results in the accumulation of hypoxanthine and xanthine	1
xanthine may also form stones	1
hypoxanthine is soluble	1
neurologic dysfunction	1
two important considerations when managing cardiovascular features of lds:	1
vascular disease is not limited to the aortic root	1
0 cm	1
0 cm and the excellent response to prophylactic surgery	1
clubfeet require surgical correction by an orthopedic surgeon	1
surgical intervention for protusio acetabulae is rarely indicated	1
treatment focuses on pain control	1
orthotics are only indicated for severe pes planus	1
some individuals prefer use of arch supports	1
others find them irritating	1
surgical intervention is rarely indicated or successful	1
cataract surgeons and glaucoma specialists may also be needed	1
others require surgery	1
most seizure disorders can be controlled with anticonvulsant therapy	1
early childhood and preschool intervention programs, e	1
kidney	1
, with surgical procedures	1
most undescended testes descend with time into the scrotum	1
some require hormone therapy and/or surgical correction	1
treatment of acute hyperammonemic crises	1
pharmacologic management	1
therapy with ondansetron can be started to decrease vomiting	1
dietary protein restriction and citrulline supplementation	1
current treatment consists of dietary protein restriction (0	1
8-1	1
5 g/kg/day in children and 0	1
lysine supplementation	1
carnitine supplemetation	1
additional therapies	1
treatment of late complications	1
however, relapses may require serial lavage	1
medical nutrition therapy	1
recurrent or persistent eruptive xanthomas indicate inadequate therapy	1
treatment is largely symptomatic	1
oxygen supplementation if necessary	1
education on complete bladder emptying when voiding	1
medical treatment of pulmonary hypertension (e	1
, by sildenafil)	1
surgical treatment of congenital diaphragmatic hernia or severe hiatal hernia	1
physical therapy for muscle strength and joint stability	1
psychosocial support	1
painful bilateral madelung deformity (uncommon)	1
audiologist	1
dietitian	1
clinical geneticist and genetic counselor	1
nurse coordinator	1
ophthalmologist	1
oral and maxillofacial surgeon	1
orthodontist	1
orthopedist	1
otolaryngologist	1
pediatric dentist	1
pediatrician	1
plastic and reconstructive surgeon	1
psychosocial professionals (psychologist, social worker)	1
speech pathologist	1
referral to a craniofacial center or otolaryngologist is recommended	1
face	1
jaw and teeth	1
good oral hygiene is especially important for children with cfm	1
children should have consistent primary preventative dental care	1
early referral to an otolaryngologist is recommended	1
this surgery typically occurs after age five years	1
speech	1
ears	1
options for management of microtia include the following:	1
no action	1
prosthetic management, either adhesive or implant-retained	1
family and social support	1
crmo is treated as follows:	1
thus, their efficacy in this disorder is unknown	1
physical therapy to avoid disuse atrophy of muscles or contractures	1
colon polyps and colon cancer	1
colonoscopy is effective surveillance for colon cancer	1
duodenal polyps	1
management of polyps is similar to individuals with fap	1
protusio acetabulae can be associated with pain or functional limitations	1
surgical intervention is rarely indicated	1
orthotics are indicated only in severe cases	1
surgical intervention is rarely indicated or fully successful	1
pneumothorax can be a recurrent problem	1
school-age children benefit from an individualized educational program	1
no information is available on response to specific aeds	1
fibrous dysplasia	1
the primary elements of management include the following	1
see fibrous dysplasia management (pdf):	1
see precocious puberty management in girls (pdf)	1
see gonadal involvement management in boys (pdf)	1
, letrozole) [boyce et al 2012]	1
thyroid disease	1
see hyperthyroidism management (pdf)	1
methimazole is effective for management of hyperthyroidism	1
the risk may potentially be enhanced by radiation exposure	1
growth hormone (gh) excess	1
see gh excess: management (pdf)	1
medical therapy is the preferred first-line treatment	1
fgf23-mediated phosphate wasting	1
hypercortisolism	1
see hypercortisolism management (pdf)	1
definitive treatment includes surgical removal of the diseased adrenal glands	1
care by a nephrologist is recommended	1
gout prevention with allopurinol or probenecid should be considered	1
kidney disease	1
kidney transplantation cures adtkd-umod	1
treatment of psychiatric problems according to the clinical presentation	1
antiepileptic drugs (aeds) for treatment of seizures	1
early-onset	1
nutrition/weight	1
weight needs to increase annually by small increments	1
gastroesophageal reflux is treated as needed	1
respiratory function testing	1
assistance with coughing	1
noninvasive ventilation support is indicated in the setting of:	1
daytime hypercapnea and/or nocturnal hypoventilation	1
toddlers often fight the masks	1
non-ambulant children require standing frames for postural support	1
late-onset	1
antiepileptic drugs should be used to treat seizures	1
additional management in healthy adults who have the 15q13	1
, schizophrenia)	1
routine treatment of ophthalmologic, cardiac, neurologic findings	1
speech, occupational, and physical therapies	1
because manifestations of 16p12	1
early diagnosis and treatment facilitate the best outcome	1
developmental and cognitive delays	1
initiate developmental therapies promptly when indicated	1
individuals with 16p12	1
psychiatric and/or behavior problems	1
standard treatment should be provided for hearing loss	1
other malformations	1
mody5	1
neurodevelopmental/neuropsychiatric disorders	1
routine medical care by a pediatrician or other primary physician	1
speech therapy directed at improving verbal and nonverbal communication skills	1
the seizures usually are easy to control with medication	1
treatment for cryptorchidism if indicated	1
routine treatment of ophthalmologic, cardiac, and neurologic findings	1
speech, occupational, and physical therapies, as appropriate	1
early speech and language therapy to address speech delays	1
individualized education program (iep) for school-age children	1
applied behavioral analysis or other treatment for manifestations of asd	1
ataxia may require assistive devices or eventually wheelchair	1
consultation with a speech pathologist may be helpful	1
cognitive impairment	1
developmental stimulation including speech therapy is appropriate	1
treatment is nonspecific	1
predisposition to infections	1
all vaccines should be given	1
gastrointestinal dysfunction	1
for (progressive) spasticity	1
for excessive drooling	1
patients experienced great improvement (e	1
for failure to thrive	1
no therapy is available for peo or retinopathy	1
physical therapy should be implemented in individuals after strokes	1
seizures respond to traditional anticonvulsant therapy	1
standard analgesics can be used for migraine headaches	1
cardiac manifestations can benefit from standard pharmacologic therapy	1
phpt	1
subtotal parathyroidectomy (i	1
removal of ≤3	1
pituitary tumors	1
prl-secreting tumors (prolactinomas)	1
growth hormone-secreting tumors	1
acth-secreting tumors	1
non-secreting pituitary adenomas	1
gastrinoma	1
pancreatic tumors	1
the optimal therapy of gastrinoma is controversial	1
occult metastatic disease (i	1
carcinoid tumors	1
adrenocortical tumors	1
medullary thyroid carcinoma (mtc)	1
menkes disease	1
surgery for bladder diverticula that occur in classic menkes disease	1
developmental intervention	1
atp7a-related dmn	1
physical therapy (strength and stretching exercises)	1
occupational therapy	1
ankle foot orthotics	1
the seizure disorder can be treated with conventional anticonvulsant therapy	1
clonazepam can also reduce myoclonus	1
physical therapy is helpful for any impaired motor abilities	1
standard pharmacologic therapy is used to treat cardiac symptoms	1
mandibulofacial dysostosis	1
see esophageal atresia/tracheoesophageal fistula overview	1
thumb anomalies	1
other thumb anomalies are not generally functionally significant	1
short stature is managed expectantly	1
treatment of scoliosis by spinal fusion is appropriate	1
orthoses are indicated for treatment of foot drop	1
discontinue use of potent inhalation agents and succinylcholine	1
increase minute ventilation to lower end-tidal co2	1
get help	1
prepare and administer dantrolene: 2	1
5 mg/kg initial dose	1
tachycardia, hypercarbia, and muscle rigidity respond rapidly	1
multiple doses of dantrolene may be needed	1
the suggested upper limit is 10 mg/kg	1
however, more may be given as needed	1
continue dantrolene at 1	1
dantrolene may aggravate previously existing muscle weakness	1
begin cooling measures	1
stop cooling measures at core body temperature of 38	1
5° c	1
treat cardiac arrhythmias as needed	1
do not use calcium channel blockers	1
check values every six to 12 hours	1
the earliest sign of rhabdomyolysis is myoglobinuria/myoglobinemia	1
serum ck levels may not rise for several hours	1
ensure urine output of 2	1
evaluate need for invasive monitoring and continued mechanical ventilation	1
myoglobinuria	1
physical habilitation	1
standard care for other medical issues (e	1
therapy is supportive and involves the following:	1
special education programs tailored to the needs of the individual	1
speech and language therapy	1
behavioral therapy as needed	1
occupational therapy as needed	1
community services that provide support for families	1
ritalin® may be helpful to treat marked hyperkinesia	1
objective efficiency of gh therapy has not been evaluated	1
use of a prosthesis in severe microphthalmia and anophthalmia	1
, fitting stockings, massage) is important	1
adaptation of the school environment (e	1
no definitive treatments exist for the limb-girdle muscular dystrophies	1
standard treatment is indicated for the following:	1
polydactyly and syndactyly	1
anal anomalies and hirschsprung disease (surgical treatment)	1
joint	1
intellectual impairment in ml ii is rarely severe	1
severe gingival thickening can compromise routine dental cleaning	1
otic	1
the recommended dose is 1 mg/kg monthly	1
bone density needs to be monitored closely	1
the long-term effect(s) are unknown	1
sillence, personal communication]	1
not all affected individuals benefit from bisphosphonate treatment	1
the prevalence decreases with age	1
psychosocial support of patients and families is recommended	1
management of pain in the hips is required	1
surgical correction of strabismus	1
speech therapy as needed	1
pulmonary function and vision may also need attention	1
stabilization of critically ill individuals	1
volume replacement with isotonic solutions	1
adequate kcals must be delivered	1
once symptoms appear, treatment is primarily supportive	1
management of gi dysfunction can include the following:	1
trial of dromperidone for nausea and vomiting	1
celiac plexus block with bupivicaine	1
physical therapy and occupational therapy to help preserve mobility	1
activity as tolerated should be encouraged	1
osteopenia and osteolysis	1
at present no specific therapy can alleviate the progressive osteopenia	1
nonsteroidal anti-inflammatory drugs may not provide sufficient relief	1
provide medical or surgical interventions as appropriate	1
monosomy 7 in children with de	1
novo aml (i	1
eye anomalies	1
notched or bifid nose	1
rhinoplasty may be performed for cosmetic purposes	1
anal stenosis is generally managed by serial dilatations	1
the cardiomyopathy may respond to ace inhibitors or other medication	1
cardiac consultation is recommended	1
kyphoscoliosis may be treated with surgical stabilization of the spine	1
there is no treatment for spinal rigidity	1
these agents are not widely used in children	1
renal allografts	1
001)	1
005)	1
allograft survival appears to be age-dependent in ddd	1
neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia)	1
epilepsy may require long-term antiepileptic treatment	1
developmental delays	1
joint replacement and atlanto-occipital stabilization may be necessary	1
repeated surgery may be required	1
cardiac valve replacement should be considered early	1
hearing aids should also be considered	1
ent (otolaryngologic)	1
gastrointestinal system	1
hydrocephaly	1
early surgical intervention may prevent severe complications	1
physical therapist to optimize mobility	1
occupational therapist to optimize autonomy	1
psychological support to optimize coping skills and quality of life	1
educational professions to optimize learning in a medically fragile individual	1
home care for affected individuals with multiple medical equipment needs	1
hospice for end-of-life care	1
enzyme replacement therapy (ert)	1
the recommendation dose is 2 mg/kg/week intravenous	1
upper extremities	1
knee and ankle valgus	1
however, no absolute indications for intervention exist	1
hip dysplasia	1
affected individuals undergoing surgical fusion typically do well	1
lumbar spine malalignment	1
when kyphosis exceeds 45 degrees, progression is likely	1
progressive thoracolumbar kyphosis greater than 70 degrees	1
uncontrolled back pain	1
neurologic changes related to spinal stenosis	1
thus tachycardia treatment with beta blockers should be avoided	1
restrictive lung disease is managed by supportive treatment	1
learning environment	1
cataract surgery may benefit those with cataracts	1
orthodontic management to correct malocclusion may be necessary	1
prevention of hypoglycemia requires frequent feeds and avoidance of fasting	1
hepatocellular carcinoma	1
treatment of muscular manifestations is symptomatic	1
cataracts are removed surgically during the first decade of life	1
hypergonadotropic hypogonadism (i	1
home therapy	1
acute decompensation	1
indication for hospitalization	1
number	1
vomiting and viral gastroenteritis	1
viral bronchiolitis	1
sinusitis	1
neonatal encephalopathy	1
urinary tract infection	1
cellulitis	1
influenza	1
viral meningitis	1
bacterial pharyngitis	1
esophageal candidiasis	1
appendicitis	1
the primary goals of in-hospital therapy	1
25 mosm/l per hour	1
minimize exposure to hypotonic fluid sources	1
the most commonly encountered are hypokalemia and hypophosphatemia	1
methods of achieving these goals	1
identify and treat precipitating conditions (e	1
, infection, inflammation, and fever)	1
administer antiemetics (e	1
, odansetron 0	1
15 mg/kg/dose) to control nausea and vomiting	1
provide at least 1	1
10 units/kg/hour and titrated to maintain euglycemia	1
5 g/kg/day	1
provide specific amino acid supplements during metabolic crisis:	1
isoleucine and valine	1
20-120 mg/kg/day each	1
glutamine and alanine	1
tyrosine	1
strauss & morton, unpublished observation]	1
nutrient	1
age in months (# of persons)	1
0-2 (31)	1
3-5 (18)	1
6-8 (21)	1
9-12 (18)	1
13-18 (21)	1
19-24 (18)	1
25-36 (32)	1
leucine (mg)	1
72(64-84)	1
58(47-68)	1
44(37-51)	1
35(30-41)	1
33(26-39)	1
27(22-28)	1
21(20-25)	1
energy (kcal)	1
111(103-119)	1
99(94-107)	1
89(82-99)	1
78(71-87)	1
67(55-77)	1
57(49-71)	1
38(39-51)	1
total protein (g)	1
1-2	1
5(1	1
isoleucine supplement (mg)	1
4(0-7)	1
3(0-3	1
7(0-3	1
6(0-3	1
8(2	1
1-5	1
7(1	1
5(3	1
valine supplement (mg)	1
5(9	1
8-14	1
4(9	1
0-13	1
0(9	1
5-12	1
1(6	1
8(5	1
4-10	1
2(2	1
8(4	1
9-8	1
alanine intake (mg)	1
233(200-262)	1
209(197-234)	1
206(193-225)	1
189(168-218)	1
178(159-199)	1
159(140-192)	1
117(114-149)	1
glutamine intake (mg)	1
416(361-471)	1
363(337-405)	1
358(332-400)	1
320(288-371)	1
294(252-337)	1
256(221-318)	1
184(181-235)	1
iron (mg)	1
1(2	1
6-2	1
8(1	1
zinc (mg)	1
6(3	1
1-4	1
4-4	1
9-4	1
6(2	1
6-3	1
selenium (µg)	1
0(5	1
7-6	1
7(4	1
8-6	1
7(5	1
3-6	1
3(4	1
4-6	1
0(4	1
0-4	1
378(307-401)	1
330(307-378)	1
330(307-354)	1
307(260-354)	1
307(283-330)	1
283(236-330)	1
212(212-260)	1
leucine / energy ratio (mg/kcal)	1
65(0	1
57-0	1
72)	1
58(0	1
48-0	1
66)	1
56)	1
46(0	1
37-0	1
53)	1
48(0	1
38-0	1
54(0	1
44-0	1
55)	1
control of brain edema	1
measure head circumference and fontanel size in neonates	1
papilledema	1
disorientation, combativeness	1
depressed level of consciousness	1
refractory vomiting	1
extremity hyperreflexia	1
bradycardic hypertension	1
hyperactive gag	1
pupillary asymmetry	1
ophthalmoplegia	1
decorticate posturing	1
methods to minimize the possibility of brain swelling:	1
elevate the individual's head	1
note: give furosemide (0	1
methods to manage brain swelling:	1
furosemide: 0	1
0 mg/kg, followed by	1
mannitol: 0	1
0 g/kg over 60 minutes, followed by	1
hypertonic (3%-5%) saline: 2	1
5 meq/kg over 60 minutes	1
neuroimaging	1
hemodialysis/hemofiltration	1
other potential complications in hospitalized persons with msud:	1
monitor for and promptly treat hospital-acquired infections	1
superficial and invasive candida infections are common	1
the management of enlarged parietal foramina is generally conservative	1
associated headaches or seizures should be treated symptomatically	1
appropriate rehabilitation, e	1
enrollment in educational programs appropriate for the hearing impaired	1
for mild keratoderma, use of lotions and emollients	1
for severe keratoderma, dermatologic evaluation	1
treatment by a psychiatrist for those with significant neuropsychiatric symptoms	1
tracheostomy as indicated for difficulty managing secretions	1
prevention strategies under investigation	1
other disciplines are involved as needed	1
this procedure is usually transcranial (i	1
severe initial clinical presentation requiring a staged repair	1
postoperative increased icp	1
recurrent deformity requiring a second transcranial repair:	1
seven (24	1
1%) of 29 individuals with the p	1
3%) of 47 without the pathogenic variant	1
048) [thomas et al 2005]	1
15 were expected to undergo extracranial contouring	1
note that none had increased icp	1
hearing loss is often sensorineural	1
strabismus surgery/correction is indicated to prevent amblyopia	1
evaluation for hscr and ultrashort hscr	1
referral to a urologist or nephrologist as indicated	1
bleeding tendency	1
suturing for treatment of accidental or surgical wounds	1
mouthwash with tranexamic acid may control gingival bleeding	1
eltrombopag	1
antifibrinolytic agents	1
ten of them benefited from cochlear implants	1
glomerular nephropathy	1
dialysis or kidney transplantation is required in individuals with esrd	1
cataract surgery remedies clouding of the lens	1
elevation of liver enzymes does not require any specific treatment	1
treatment is largely symptomatic and may include the following	1
elective tracheal surgery/intubation should be avoided	1
symptomatic treatment of restrictive lung disease	1
oxygen supplementation as necessary	1
noninvasive 3d imaging may be preferred	1
neuropsychiatric	1
global developmental disability/intellectual disability educational issues	1
persistent middle ear effusions	1
myringotomy tubes as needed	1
ophthalmology	1
routine treatment of strabismus and refractive errors	1
all experienced substantial improvement of both myoclonus (61	1
5%) and dystonia (48	1
2%)	1
no adverse effects on cognition or affect were noted	1
the results of case studies are summarized below:	1
no specific therapy currently exists for this disorder	1
special education evaluation is indicated for children with dm1	1
statins)	1
pain management can be an important part of dm1 treatment	1
treatment guidelines for dm2 have been published	1
no one medication has been consistently effective	1
treatment as in the general population for:	1
glaucoma	1
supportive management includes treatment of the following:	1
treatments for nbia are palliative	1
botulinum toxin for those with focal dystonia	1
l-dopa treatment, which is beneficial in rare cases	1
some will develop prominent dyskinesias early in the treatment	1
spectacles as needed to correct refractive errors	1
orchiopexy as needed	1
trihexyphenydil improves dystonia and sialorrhea	1
general management	1
thiazide diuretics (i	1
emergency treatment for dehydration	1
5% dextrose in water is the preferred solution	1
if administration of iv fluids is required, 2	1
special situations	1
hydronephrosis, hydroureter, and megacystis	1
aggressive treatment of lower respiratory tract infections	1
standard treatment of gastroesophageal reflux, if present	1
physical therapy for maintenance/improvement of function and joint mobility	1
speech therapy if dysarthria and/or hypernasal speech is present	1
currently no cure for nephronophthisis exists	1
treatment of anemia, hypertension, and proteinuria if present	1
dialysis or renal transplantation when patients reach esrd	1
botulinum toxin is helpful for painful focal dystonia	1
further studies are in progress	1
vestibular schwannoma	1
therapy remains primarily surgical	1
small vestibular tumors (<1	1
lip-reading skills may be enhanced by instruction	1
ocular involvement	1
infections	1
the spectrum of recurrent infections in nbs is not opportunistic	1
puberty and fertility	1
females are infertile	1
similarly, no male paternity has been reported	1
no effective treatment for severe glycine encephalopathy exists	1
flusser et al 2005	1
van hove et al, unpublished]	1
it increases alertness	1
nmda receptor site antagonists	1
use of each has resulted in improved seizure control	1
this may be different in mildly affected children	1
blood concentration can be monitored	1
seizure control is important for symptomatic benefit	1
various antiepileptic drugs have been used with variable success	1
most affected individuals need physical therapy	1
scoliosis is managed with standard techniques	1
chorea	1
children: 0	1
adults: 37	1
5 mg/day starting dose divided in 2-3 doses	1
of note:	1
other neurologic manifestations	1
pulmonary dysfunction	1
treat asthma and interstitial lung disease as needed	1
thyroid hormone replacement therapy is recommended	1
there is substantial early mortality associated with hypertrophic cardiomyopathy	1
significant short stature compared with normal peers	1
documented response to gh treatment in studies	1
no standard dose has been established	1
the increase in height sd varies from 0	1
6 to 1	1
ophthalmologic evaluation is warranted	1
at 23 months of life	1
5 months) [walsh et al 2010]	1
severe neurodegenerative form (npd-a)	1
progressive neurologic disease	1
regular consultation with a dietician should be provided	1
sleep disorder	1
npd-b	1
most affected individuals have thrombocytopenia	1
individuals with symptomatic pulmonary disease may require supplemental oxygen	1
no curative therapy for npc exists	1
child syndrome	1
oral aromatic retinoids (etretinate) to ameliorate cutaneous symptoms	1
topical statins	1
dermatologic surgery	1
orthopedic abnormalities	1
other medical care as appropriate based on clinical findings	1
ck syndrome	1
antiepileptic drugs (aed) to control seizures	1
ophthalmologic management of ocular abnormalities	1
ophthalmologic care	1
surgery may improve peripheral binocularity or appearance	1
nystagmus surgery remains highly controversial	1
additional classroom aids may include:	1
high contrast reading materials (black on white)	1
large font texts or xerographically enlarged worksheets	1
computers and tablets with zoom-magnification text software	1
skin cancer is treated as for the general population	1
a hat with a brim (e	1
removal of accessory teeth	1
orthodontia for malocclusion	1
surgery to repair syndactyly, if present	1
routine management of seizures	1
physical medicine treatment	1
avoid sudden acceleration/deceleration movements	1
and avoid throwing a child in the air	1
older children should not ride on amusement park rides	1
physical activity serves a number of purposes	1
analgesics can be used to control pain from fractures	1
casts should be small and lightweight	1
these studies are still ongoing	1
a study comparing pamidronate to zoledronic acid was completed	1
to date, the results have not been published	1
basilar impression	1
criteria for surgical intervention are not well defined	1
plastic polymers are sometimes used to coat teeth	1
outcome data are limited	1
management of lethal oi	1
other therapies	1
, pulse oximeter) and ventilation (i	1
ongoing studies have not confirmed this report	1
hirschsprung disease	1
tumors of neural crest origin	1
no treatment for opa1 is of proven efficacy	1
for treatment of ataxia, see ataxia overview	1
hand and foot malformations may also require surgery	1
surgical correction of limb bowing has not been reported	1
apnea prevention	1
treatment as needed by an ophthalmologist	1
surgical intervention as needed for hypospadias	1
surgical treatment of medically significant laryngotracheoesophageal (lte) abnormalities	1
surgical management for cleft lip/palate and other craniofacial anomalies	1
neuropsychological support	1
surgical intervention for imperforate anus	1
surgical repair as needed for heart defects	1
ptosis	1
however, the procedure requires general anesthesia	1
food should be cut into small pieces	1
care of hyperammonemic coma	1
rapid lowering of the plasma ammonia	1
ammonia scavenger therapy	1
citrulline is supplemented at 170 mg/kg/day or 3	1
8g/m2/day (enterally)	1
table 2	1
patient weight	1
components of infusion solution	1
loading 1 and maintenance dose 2, 3	1
sodium phenylacetate & sodium benzoate 4	1
arginine hcl injection, 10%	1
arginine hcl 5	1
<25 kg	1
undiluted: 2	1
0 ml at 100 mg/ml	1
200 mg/kg	1
≥25 kg	1
40 ml at 100 mg/ml	1
4,000 mg/m2	1
protein intake	1
recommendations for ammonia scavenger therapy:	1
9-13	1
0 g/m2/day of sodium phenylbutyrate and 3	1
it is typically performed by age six months	1
attention deficit/hyperactivity disorder (adhd)	1
seizure disorders	1
learning disability/intellectual disability	1
also see urea cycle disorders overview	1
bleeding disorder	1
cardiac fibrosis	1
pancreatectomy	1
issues to consider prior to referral for tpiat:	1
the operation is irreversible	1
pain relief is not universal	1
chronic pancreatitis	1
cholecystokinin (cck) and its analogs (e	1
, mineral oil, olestra), or	1
, orlistat), or	1
routine screening of patients with chronic pancreatitis for glucose intolerance	1
esrd is treated with renal replacement therapy (i	1
, dialysis and/or renal transplantation)	1
registration or institutional access required)	1
most are benign and can be completely excised	1
preoperative	1
a liberal sodium diet	1
, 3 days prior to surgery)	1
postoperative	1
occupational, physical, and speech therapy are often helpful	1
treatment focuses on symptomatic therapy	1
feeding and nutrition	1
no specific metabolic diet is recommended	1
neurologic function	1
early intervention services should be provided	1
seizures are present in approximately one third of affected individuals	1
standard antiepileptic drugs (aeds) may be used	1
no type of aed is contraindicated	1
pch2	1
919g>t (p	1
ala307ser)	1
all other subtypes are very rare	1
the main problems to manage:	1
central visual impairment	1
epilepsy, which is amenable to standard treatments	1
physiotherapy can be helpful	1
pch4 and pch5	1
respiratory support is usually given for a limited time	1
palmoplantar keratoderma	1
however, trimming too aggressively can greatly increase pain	1
topical therapies to remove the hyperkeratosis:	1
occlusive ointments are often poorly tolerated	1
nail dystrophy	1
particularly troublesome nails can be successfully removed surgically	1
oral leukokeratosis	1
follicular hyperkeratosis	1
leukokeratosis with laryngeal involvement	1
cysts	1
intralesional injection of steroid (e	1
if necessary, cysts can be excised	1
at present, no specific therapies can correct ciliary dysfunction	1
, vigorous exercise)	1
routine immunizations to protect against respiratory pathogens:	1
pertussis	1
haemophilus influenzae type b	1
pneumococcal vaccine	1
annual influenza virus vaccine	1
this approach, however, is controversial	1
nasal congestion and sinus infections	1
chronic/recurrent ear infection	1
male infertility	1
situs abnormalities	1
special education programs should be offered	1
, carbamazepine, phenytoin, valproate)	1
hearing habilitation (hearing aids as early as possible)	1
educational programs designed for individuals with hearing impairment	1
provision should be made for any special educational needs	1
estrogen can be administered orally or topically	1
before considering pregnancy, uterine size should be assessed	1
depression	1
weight loss	1
additional management is symptomatic and expectant	1
thoracic society 2000, american thoracic	1
society & european respiratory society 2002]	1
transplantation are good candidates	1
five-year survival rates post transplant in	1
non-pharmologic treatments:	1
oxygen therapy may improve exercise tolerance in patients with	1
hypoxemia	1
pulmonary rehabilitation is a recommended option for patients who would	1
benefit	1
ipf	1
immunosuppressive/cytotoxic agents, and antifibrotic agents	1
however, at least	1
two antifibrotic pharmacologic interventions recently approved may be an option	1
see therapies under	1
investigation	1
no management guidelines have been published	1
the majority of individuals with pfcp require no regular treatment	1
when symptoms of the hyperviscosity syndrome are evident	1
hyperviscosity symptoms (see	1
evaluations following initial diagnosis)	1
grade 1	1
grade 2	1
in the presence of persistent symptoms perform phlebotomy	1
grade 3	1
consider additional aspirin treatment	1
thromboembolic events	1
provide acute treatment according to established practice for the event	1
evaluate for other thrombophilic risk factors	1
consider additional aspirin treatment in all patients	1
consider life-long anticoagulation (e	1
pharmacologic therapy	1
nutritional therapy and supplementation	1
nasogastric tube feeding has been useful in some infants	1
other approaches	1
interruption of the enterohepatic circulation of bile acids	1
the internal biliary bypass approach of cholecystojejunocolic anastomosis	1
liver transplantation (ltx)	1
steatohepatitis can be progressive and lead to cirrhosis	1
extrahepatic manifestations	1
the general therapies for nephrolithiasis benefit all individuals with ph1	1
patients should be advised to seek early medical attention	1
alkalinzation of urine (ph 6	1
2-6	1
15 mg/kg or 0	1
3-0	1
treatment of kidney stones	1
swl	1
ureteroscopy	1
percutaneous nephrolithotomy and ureteroscopy	1
reduction of oxalate biosynthesis	1
agt is a pyridoxal phosphate (plp)-dependent enzyme	1
7 mmol/1	1
phe152ile pathogenic allele	1
73 m2/day)	1
transplantation (tx) options:	1
simultaneous liver - kidney	1
sequential liver - kidney	1
isolated kidney	1
isolated liver	1
hemodialysis (hd) strategy:	1
perioperative ± postoperative based on pox & gfr	1
preoperative & perioperative	1
sometimes perioperative	1
ckd category / residual gfr	1
ckd category 3 (30<gfr<59)	1
option in carefully selected patients	1
ckd category 4 (15<gfr<29)	1
option	1
ckd category 5 (gfr <15)	1
infantile form (esrd <2 yrs)	1
use of deceased vs	1
living donors for either or both organs	1
, gfr >60 ml/min/1	1
adequate fluid intake (>2	1
5 l/m2 surface area/day)	1
urinary inhibitors of calcium oxalate crystallization:	1
potassium citrate (0	1
maintainance of high oral fluid intake (>2	1
5 l/m2 bsa)	1
oral administration of an inhibitor of calcium oxalate crystallization	1
avoidance of supersaturation of calcium oxalate in the blood	1
avoidance of marked dietary oxalate excess	1
simple avoidance of marked dietary oxalate excess is recommended	1
metabolic abnormalities and hypertension generally improve within one week	1
different thiazide diuretics exist, with different dosing regimens	1
anal atresia or stenosis should be treated in standard fashion	1
seizures are treated symptomatically	1
repair of polydactyly should be undertaken on an elective basis	1
if asymptomatic, observation alone is prudent	1
when symptomatic, topical agents (e	1
leg-length discrepancy secondary to segmental somatic overgrowth	1
cardiac abnormalities (i	1
, structural cardiovascular disease and arrhythmias)	1
renal abnormalities	1
speech, swallowing, and feeding difficulties	1
neurologic and neurosurgical manifestations	1
mcap syndrome	1
hmeg	1
somatic overgrowth, vascular, lymphatic and musculoskeletal manifestations	1
infant feeding assessment to address early hypotonia as needed	1
behavioral modification for self-injurious behavior or anxiety	1
eyeglasses or surgery as needed for amblyopia	1
orthopedic treatment of scoliosis as indicated	1
standard care for other medical issues	1
polyps	1
this strategy has two goals:	1
from st	1
intussusception should be treated in a standard manner	1
malignancies should be treated in a standard manner	1
intramuscular botulinum toxin	1
intrathecal and intraventricular baclofen	1
ablative pallidotomy or thalmotomy	1
referral for adaptive aids as needed (e	1
, a walker or wheelchair for gait abnormalities)	1
other manifestations	1
treatment and interventions for retinopathy as per ophthalmology	1
flank pain	1
cyst hemorrhage and gross hematuria	1
nephrolithiasis	1
5), and administration of allopurinol	1
cyst infection	1
cyst infection is often difficult to treat	1
therapeutic agents of choice include trimethoprim-sulfamethoxazole and fluoroquinolones	1
chloramphenicol has shown therapeutic efficacy in otherwise refractory disease	1
end-stage renal disease (esrd)	1
females appear to do better than males	1
complications directly related to adpkd are rare	1
polycystic liver disease	1
and the results are often short-lived	1
ruptured or symptomatic intracranial aneurysm	1
asymptomatic aneurysms	1
those aneurysms measuring 5	1
if the size increases, surgery is indicated	1
the management of aneurysms 6	1
0-9	1
0 mm in size remains controversial	1
surgical intervention is usually indicated for aneurysms larger than 10	1
aortic dissection	1
early recognition and treatment of dehydration is critical	1
and (2) the risk for ascending cholangitis	1
administration of synthetic bile acids	1
portosystemic shunting may be necessary to treat progressive portal hypertension	1
dual-organ transplantation	1
see table 2 (pdf) and figure 1	1
feeding and growth	1
see acmg management guidelines for pku	1
treatment of classic pku	1
restriction of dietary phenylalanine	1
maintain blood tyr in the normal range	1
sapropterin (kuvan®)	1
reviewed in ho & christodoulou [2014]	1
large neutral amino acids (lnaa) transporters	1
treatment for non-classic hyperphenylalaninemia	1
neuropsychiatric testing may be considered to identify learning differences	1
bone health assessment	1
only symptomatic treatment is available	1
epileptic seizures may worsen the individual's condition	1
those with severe dysphagia may require feeding by gastrostomy	1
response to pharmacologic treatment is poor	1
however, clonazepam or diazepam can be effective	1
no disease-modifying drug treatment exists for pnpla6-related disorders	1
speech therapy [sapir et al 2003]	1
swallowing therapy	1
assistive walking devices and ankle-foot orthotics	1
, baclofen [oral or intrathecal], tolperison	1
botox® injections) and urinary urgency (e	1
hypothyroidism is treated with thyroid hormone replacement (e	1
, levothyroxine) at the time of diagnosis	1
dysphagia management is therefore important	1
hypersalivation is managed with the multidisciplinary team and an otolaryngologist	1
treatment must be individualized	1
therapies to consider include rehabilitation (e	1
, oromotor therapy, behavioral therapy)	1
medical therapy (e	1
, anticholinergic medications, botulinum toxin injections)	1
and, in severe cases, surgery (e	1
learning difficulties are likely to progress slowly	1
patients should be followed regularly by an endocrinologist	1
patients need to be followed regularly by an ophthalmologist	1
the following treatment is recommended:	1
speech therapy for those with language impairment	1
occupational therapy for those with language impairment	1
severe obesity	1
therefore, lifestyle measures should be instigated	1
fair skin	1
growth hormone (gh) deficiency	1
treatment is highly effective	1
iron reduction	1
iron chelation therapy (e	1
serum ferritin concentration should be measured before starting phlebotomy treatment	1
for persons with the hfe genotypes p	1
cys282tyr or p	1
low-dose anti-malarial agents	1
combining both treatment modalities (i	1
pct may also improve after treatment of coexisting hepatitis c	1
pct should be treated first in most individuals:	1
neurovisceral symptoms	1
most acute neurovisceral attacks require hospital admission	1
harmful medications should be discontinued	1
cutaneous symptoms	1
patients should wear protective clothing and avoid exposure to sunlight	1
topical steroids are of little or no benefit	1
strabismus and/or refractive errors	1
standard treatment as recommended by ophthalmologist	1
dental crowding / malocclusion	1
evidence of sleep apnea	1
standard treatment as indicated	1
diet diary & calorie counts may be requested	1
hypoglycemia, short stature, evidence of growth hormone deficiency	1
standard treatment(s) as recommended by endocrinologist	1
standard treatment as recommended by cardiologist	1
renal anomaly and/or vesicoureteral reflux	1
standard treatment as recommended by nephrologist/urologist	1
enrollment in dda (developmental disabilities administration) is recommended	1
, scoliosis)	1
consider:	1
evaluation for alternative means of communication (e	1
pleuropulmonary blastoma (ppb)	1
individuals receiving neoadjuvant chemotherapy may have marked tumor reduction	1
chemotherapy alone is insufficient to eradicate solid ppb	1
pleural effusions	1
drainage of pleural effusions should be approached with caution	1
surgery for metastases	1
therapeutic resection of bone and liver metastases is rarely indicated	1
type i ppb	1
types ii and iii ppb	1
aggressive chemotherapy is necessary	1
ppbregistry	1
radiation therapy	1
treatment failure	1
ovarian sex cord-stromal tumors	1
sertoli-leydig cell tumor	1
juvenile granulosa cell tumor (jgct)	1
hyperthermic chemotherapy has been used by some investigators	1
gynandroblastoma	1
the malignant potential of gynandroblastoma is not yet clear	1
cystic nephroma	1
multinodular goiter (mng) and thyroid cancer	1
observation with or without biopsy	1
ciliary body medulloepithelioma (cbme)	1
the four management options include:	1
observation	1
local resection	1
however, many of these tumors will progress	1
enucleation	1
long-term survival is common after this definitive therapy	1
orbital exenteration	1
nasal chondromesenchymal hamartoma (ncmh)	1
however, complete extirpation is preferred	1
pituitary blastoma	1
pineoblastoma	1
immediate management issues may include interventions for obstructive hydrocephalus	1
an aggressive surgical approach is associated with prolonged survival	1
medications in use for pah include the following:	1
endothelin blockers (oral)bosentanambrisenanmacitentan	1
phosphodiesterase inhibitors (oral)sildenafiltadalafil	1
guanylate cyclase stimulator (oral)riociguat	1
calcium channel blockers	1
adjunctive agents	1
mean survival after lung transplantation is about five years	1
no specific therapy for ppd is available	1
pain due to secondary osteoarthritis may respond to nsaids	1
physical therapy may help preserve joint mobility	1
immobilization (e	1
, casting) should be avoided	1
angular deformities of lower limbs	1
progressive joint stiffness	1
, hip and knee replacement)	1
progressive stiffness and deformities of the spine	1
scoliosis and mild kyphosis can be managed with bracing	1
therapy is aimed at controlling symptoms that may cause discomfort	1
myoclonus can sometimes be mitigated by clonazepam	1
issues related to dysphagia are often difficult to resolve	1
no curative treatment is available	1
care is preferably provided by a multidisciplinary team	1
growth hormone	1
, recombinant) gh	1
tsh	1
lh and fsh	1
usually sex steroids are used to maintain secondary sex characteristics	1
acth	1
neonatal/acute decompensation	1
in-patient management	1
assess and manage ventilation and circulation as necessary	1
determine the need for sepsis workup and antibiotics	1
reverse catabolism by giving intravenous glucose and lipids	1
dextrose solutions exceeding the concentration of 12	1
5% require a central line placement	1
additional calories can be provided using parenteral lipid emulsion	1
manage protein intake to reduce propiogenic precursors	1
remove toxic compounds	1
pharmacologic detoxification:	1
oral n-carbamoylglutamate (carglumic acid	1
manage pancreatitis using standard practices	1
home management of metabolic status	1
at-home detection and monitoring of urine ketones	1
diet modification under the direction of the metabolic team	1
management of arrhythmias is similar to that from other causes	1
dermatologic manifestations (e	1
evaluation for dvts	1
evaluation of pe	1
bullous pulmonary disease	1
psychosocial issues	1
0 mg/dl (360 μmol/l)	1
febuxostat, a newer urate-lowering xanthine oxidase inhibitor	1
note: excretion of >1	1
high daily fluid intake (i	1
, ≥2 l/day in the adult)	1
xanthinuria does not respond to urinary alkalinization	1
several expert groups (e	1
giessen, germany)	1
burtonsville, md)	1
cholecystokinin (cck) and its analogues (e	1
13c-mixed triglyceride breath test	1
72-hour fecal fat	1
sudan stain	1
, mineral oil, olestra)	1
, orlistat)	1
chronic pancreatitis is associated with a gradual loss of function	1
surgical methods are standard	1
a target inr of 2	1
5 (therapeutic range: 2	1
anticoagulation is recommended:	1
indefinitely for those with recurrent idiopathic vte	1
cognitive/developmental delay	1
see global developmental disability/ intellectual disability educational issues	1
management by a neurologist	1
, dystonia, dyskinesia, dysconjugate eye movements)	1
vision deficits	1
correction of refractive errors	1
vision support	1
standard treatment for strabismus & exophoria	1
supplementary oxygen (at night) & rarely tracheostomy	1
ambulatory peripheral saturation monitoring may be required	1
congenital heart defect	1
frequent aspiration (or high risk of aspiration)	1
a percutaneous endoscopic gastrostomy tube may be considered	1
medical management	1
referral to a gastroenterologist may be required in severe cases	1
congenital urogenital defect	1
management as per current practice for the specific urogenital defect	1
progressive neuropathic scoliosis may require spinal fusion	1
osteoporosis/osteopenia	1
instability in standing position	1
neuropathic hip dysplasia, progressive subluxation, & dislocation	1
consideration of hip reconstructions w/varus derotational proximal femoral osteotomies	1
vitamin d deficiency	1
vitamin d supplementation	1
anterior pituitary hormone deficiencies	1
standard treatment as directed by an endocrinologist	1
global developmental disability/ intellectual disability educational issues	1
, scoliosis, hip dislocation)	1
, feeding, grooming, dressing)	1
feeding, hyperphagia, and obesity	1
therapies, education and behavior management	1
initiate appropriate educational programming in children:	1
social skills training groups have been beneficial	1
however, preservation of fertility is not an issue	1
standard treatment is appropriate	1
angulo & miller, unpublished data]	1
schulze et al 2001	1
vats & cassidy, unpublished data]	1
sleep issues	1
skin picking	1
management of strabismus is as for any infant	1
adulthood	1
affected individuals generally require a sheltered employment environment	1
no specific treatment for pxe exists	1
for all phenotypes	1
occupational therapy to maximize motor function	1
speech therapy for dysarthria	1
rdp	1
standard therapies for the following are appropriate:	1
ahc	1
episode prophylaxis (avoiding triggers	1
prophylactic medications	1
flunarizine	1
chloral hydrate	1
other sleep inducers	1
epilepsy management utilizes existing anticonvulsants	1
capos syndrome	1
symptomatic treatment includes hearing and visual aids	1
capillary malformations (cms)	1
avms/avfs	1
, embolization vs	1
surgery)	1
cardiac overload	1
hemihyperplasia and/or leg length discrepancy	1
lymphangiography to evaluate for lymphatic malformations may be considered	1
prostheses	1
intervention and/or special education if developmental delays are detected	1
cataract extraction may preserve some vision	1
orthopedic procedures have improved function in some individuals	1
dietary restriction of phytanic acid intake	1
avoidance of sudden weight loss	1
lifelong treatment with hydrating creams	1
treatment of acute presentation	1
treatment options for the eye include enucleation	1
cryotherapy	1
radiation therapy using episcleral plaques	1
legal use of telescopic lenses may vary by locale	1
retinoschisis affects primarily the inner retinal layers	1
psychosocial support for families is an integral part of management	1
they are tolerated better than milk of magnesia	1
high dose supplementation	1
supportive care	1
respiratory support	1
physiotherapy to avoid contractures	1
occupational therapy for support in activities of daily living	1
orthotics for limb and trunk bracing	1
speech and language therapy to avoid choking and respiratory problems	1
wheel chair as needed	1
low vision aids for those with decreased visual acuity	1
routine management of scoliosis to avoid long term respiratory problems	1
routine management of depression	1
pharmacologic treatment focuses on improving pain and correcting bone deformation	1
low dose	1
high dose	1
50 to 0	1
75 µg daily	1
in these individuals, surgical treatment is frequently pursued	1
the literature consists of case series	1
craniofacial treatment	1
sensorineural hearing loss has been reported in persons with xlh	1
see hereditary hearing loss and deafness overview, management	1
corrective surgeries may be required for repair of:	1
abnormal penile insertion/penoscrotal position	1
hormone therapy may be helpful for males with micropenis	1
orthodontic treatment is typically required	1
corrective surgeries may be required for the following:	1
syndactyly repair	1
severe scoliosis secondary to hemivertebrae and rib abnormalities	1
cleft lip and cleft palate repair	1
hormone therapy should be monitored by a pediatric endocrinologist	1
orthodontic treatment is usually required	1
no treatment is required	1
cystoid macular edema (cme)	1
optical aids	1
however, its current cost limits widespread use	1
retinal prostheses	1
agencies for the visually impaired	1
general management guidelines for those with systemic involvement:	1
nutritional support (e	1
management may include consideration of tracheostomy and artificial ventilation	1
referral to a pediatric neurologist for seizure management	1
of note, seizures may be refractory to treatment	1
aggressive management of fever and infection	1
5 epimutations possibly because children with 11p15	1
initial treatment is use of a shoe lift	1
neurodevelopment	1
gastrointestinal disorders should be aggressively managed	1
craniofacial anomalies	1
orthognathic surgery is rarely required	1
referral of males with cryptorchidism to a urologist	1
referral of males with micropenis to an endocrinologist	1
androgenic hormone therapy as indicated	1
neoplasia	1
standard treatment for hearing loss if identified	1
standard treatment for cardiac defects if identified	1
aggressive management of gastroesophageal reflux and constipation	1
standard treatment for cryptorchidism if identified	1
surgical repair of significantly angulated thumbs or duplicated halluces	1
appropriate treatment for sleep apnea if identified	1
visually significant cataracts require surgical removal	1
complete cessation of symptoms is the goal	1
it is therefore important that:	1
adequate posture should be maintained when lying prone and sitting	1
hematologic manifestations	1
treatment is symptomatic:	1
sensory axonal neuropathy	1
physiotherapy and orthoses to prevent foot and spine deformity	1
supportive shoes, splints, and braces	1
foot care to treat calluses and ulcerations	1
a walker, wheelchair, physiotherapy, occupational therapy	1
some patients have benefited from lamotrigine or levetiracetam	1
psychiatric symptoms	1
canes and walkers help prevent falling	1
occupational therapy, including home adaptations	1
physiotherapy and assessment for cane and wheelchair	1
ankle-foot orthotics (afos) for those with neuropathy	1
modest success has been observed in some affected individuals	1
supplements of antioxidants, which may have some beneficial effects	1
treatment of psychiatric syndromes as needed	1
technical assistance with writing and other fine-motor tasks	1
epileptic seizures can be improved by treatment with anticonvulsive medications	1
treatment of seizures with antiepileptic drugs (aeds)	1
treatment of dystonia with local injections of botulinum toxin	1
at present, only symptomatic treatments are available	1
these include the following:	1
crutches (less often canes) and walkers	1
speech/language therapy for dysarthria and swallowing difficulties	1
surgical intervention as needed for severe ptosis	1
symptoms of restless legs syndrome may respond to these agents	1
non-pharmacologic therapy is important in sca3:	1
specific treatment for sca36 is currently not available	1
walking aids to facilitate ambulation and mobility	1
the use of a wheelchair is rare	1
speech therapy and communication devices for those with dysarthria	1
the utility of cochlear implants in sca36 is unknown	1
vestibular suppressants may reduce vertigo and/or osscilopsia	1
canes, walking sticks, and walkers help prevent falling	1
note: rbd is rare in individuals with sca6	1
continuous positive airway pressure may be used for sleep apnea	1
cerebellar ataxia	1
retinal degeneration	1
use of canes and walkers helps prevent falls	1
compound heterozygous for pathogenic variant and a susceptibility variant	1
free carnitine levels were normal in all individuals	1
no published treatment guidelines exist	1
, dravet syndrome	1
see scn1a-related seizure disorders and differential diagnosis)	1
sodium channel blockers	1
other aeds	1
vagus nerve stimulator	1
cannabinoids	1
sleep hygiene	1
it prevents the following:	1
in most cases, cranioplasty precedes palatal repair	1
ophthalmologic abnormalities are treated in a standard fashion	1
routine monitoring (see surveillance) is recommended	1
hematologic abnormalities	1
prompt treatment of hypoglycemia if present	1
ophthalmologist for management of vision problems	1
neurologist if seizures are present	1
oncologist if a tumor is identified	1
surgical intervention for aneurysms may be indicated	1
surgical repair of abdominal hernias may be indicated	1
cleft palate and craniosynostosis require management by a craniofacial team	1
surgical fixation of cervical spine instability may be necessary	1
clubfoot deformity may require surgical correction	1
pectus excavatum may be severe	1
rarely, surgical correction is indicated for medical reasons	1
physiotherapy	1
physiotherapy may help increase mobility in individuals with joint contractures	1
axenfeld-rieger anomaly or related anterior chamber ocular anomalies	1
dental anomalies	1
insulin resistance/diabetes mellitus	1
a systematic approach to pain management should be reviewed regularly	1
vaso-occlusive pain episodes (including dactylitis)	1
, cold, dehydration)	1
nsaids (e	1
fever/suspected infection	1
individuals with temperature greater than 38	1
rapid triage and physical assessment	1
urgent cbc and reticulocyte count	1
acute chest syndrome (acs)	1
perform chest x-ray examination	1
incentive spirometry should be encouraged	1
aplastic crisis	1
blood transfusion may be necessary	1
splenic sequestration	1
pulmonary hypertension	1
the following general approach is reasonable:	1
, thrombotic disease, obstructive sleep apnea)	1
optimization of scd-related therapy to stop progression (e	1
stroke	1
cerebral hemorrhage requires immediate neurosurgical consultation	1
chronic transfusion has been shown to reduce silent infarcts	1
priapism	1
there is no effective treatment for xlsa/a	1
weighted eating utensils may help promote independent skills in childhood	1
speech therapy may improve intelligibility problems resulting from dysarthria	1
hepatic and systemic iron overload does not occur	1
orthopedic manifestations	1
treatment of scoliosis and/or kyphosis is standard	1
immunologic manifestations	1
individuals with autoimmune problems have had variable responses to treatment	1
infectious disease manifestations	1
hypothyroidism can be treated with levothyroxine supplementation	1
chelation therapy	1
monitoring includes the following:	1
complete blood count	1
assessment of liver function	1
assessment of iron status	1
treatment may need to be discontinued if:	1
white blood count is <3	1
5x109/l	1
neutrophil count is <2	1
0x109/l	1
platelet count is <150x109/l	1
although the role of atypical tranquilizers (e	1
treatment of status dystonicus	1
standard protocols are used in an intensive care setting	1
cholesterol supplementation	1
dental management can be challenging	1
recurrent otitis media may require tympanostomy tube placement	1
see spinal muscular atrophy	1
feeding/growth	1
manage gastroesophageal reflux disorder in the standard manner	1
use oral suctioning as needed	1
in some cases artificial ventilation and tracheostomy may be employed	1
manage accordingly	1
health issues specific to sma	1
scoliosis occurs frequently in individuals with sma ii	1
no surgical complications were identified	1
hip dislocation is another orthopedic concern in sma	1
ongoing pediatric care with regular immunizations	1
[hildenbrand & smith 2012]	1
no well-controlled treatment trials have been reported:	1
thus, dosages may not be exact	1
enclosed bed system for containment during sleep	1
treatment with diet or medication as indicated	1
treatment with corrective lenses as indicated for ophthalmologic abnormalities	1
treatment of recurrent otitis media with tympanostomy tubes as needed	1
the bones in sclerosteosis are thick and dense	1
surgical intervention may be difficult and prolonged	1
standard neurosurgical instruments may not be sufficient (i	1
tooth extraction may be difficult	1
management by an orthodontic or craniofacial team is recommended	1
when clinical problems (e	1
care includes:	1
early referral to an experienced multidisciplinary team	1
referral to special educational services for visually impaired infants	1
referral to endocrinologist for growth or hypogonadism concerns	1
referral to physiotherapist if any evidence of motor impairment exists	1
referral to special educational services for neurodevelopmental problems as needed	1
parent/caregiver training in seizure management	1
no specific drug treatment or cures exist for spg11	1
physiotherapy for stretching of the spastic muscles to prevent contractures	1
anti-spastic drugs such as baclofen and tizanidine	1
anticholinergic drugs are indicated for urinary urgency	1
psychiatric manifestations should be treated in accordance with standard practice	1
physiotherapy is appropriate	1
foot deformities are corrected by surgical treatment	1
improve muscle strength (through resistance exercise)	1
improve cardiovascular fitness	1
oxybutynin is helpful in reducing urinary urgency	1
see also hereditary spastic paraplegia overview	1
spasticity can be treated with:	1
oral baclofen or tizanidine	1
chemodenervation with botulinum a or b toxins	1
intrathecal baclofen pump	1
see also prevention of secondary complications	1
referral to orthotic services may be helpful	1
urinary urgency can be treated with anticholinergic antispasmodic drugs	1
symptomatic treatment includes use of the following:	1
antispastic drugs for leg spasticity	1
anticholinergic antispasmodic drugs for urinary urgency	1
regular physiotherapy for stretching of spastic muscles	1
no specific drug treatments or cures exist for spg7	1
antispasmodic drugs (e	1
no significant toxicity limits their use	1
routine treatment of inguinal herniae	1
surgical intervention as needed if scoliosis is significant	1
l-dopa (0	1
optimal therapeutic level is determined by clinical response	1
tetrahydrobiopterin (bh4	1
monoamine oxidase inhibitors (selegeline)	1
serotonin reuptake inhibitors (sertraline)	1
melatonin	1
dopamine agonists (bromocriptine, pramipexole)	1
anticholinergics	1
methylphenidate	1
5 years [escalera et al 2010]	1
and speech therapy [gropman 2003]	1
refractive errors should be corrected with spectacles	1
myringotomy tubes are often required	1
some of these treatments have only been partially effective	1
current treatment therapies focus on the following:	1
treatments should begin at the time of diagnosis	1
often existing xanthomas regress	1
partial ileal bypass surgery (i	1
sitosterolemia does not respond to standard statin treatment	1
global developmental delay, cognitive dysfunction and intellectual disability	1
seizure management is symptomatic	1
other neurologic findings	1
bracing for scoliosis and kyphosis	1
blepharoplasty for significant ptosis	1
hearing aids and/or cochlear implantation for sensorineural hearing loss	1
agents such as gabapentin should be considered	1
gentle handling may reduce pain that is worsened with movement	1
splinting of affected joints may provide comfort	1
consultation with a pain management specialist may be helpful	1
palliative care may be an option in severe cases	1
a nutritionist should follow affected individuals	1
protein-losing enteropathy	1
an effective long-term treatment is lacking	1
dermatitis	1
perianal masses may be excised, but may recur	1
contractures are typically progressive	1
immune system/infections	1
the treatment for thrombocytopenia is platelet transfusion as needed	1
but the clinical response is unpredictable and generally poor	1
the management of epilepsy in many genetic epilepsies is complex	1
refer to an urologist or nephrologist as indicated	1
manage according to the anomalies detected	1
imperforate anus	1
immediate surgical intervention is required	1
thumb malformations	1
, removal of additional thumbs)	1
birth to 2 years: airway and feeding difficulties	1
13 years to 18 years: orthognathic surgery	1
generally, bone reconstruction precedes soft tissue corrections	1
reconstruction can prevent the progression of facial asymmetry	1
maxillomandibular reconstruction	1
orthognathic procedures are typically indicated before age 16 years	1
misaligned teeth often require orthodonture	1
nasal reconstruction, if needed, should follow orthognathic surgeries	1
other measures:	1
medication to control seizures, as in the general population	1
shunt placement, when hydrocephaly is identified	1
suboccipital decompression for relief of craniocervical junction constriction	1
hearing aids, when hearing loss is identified	1
supplemental oxygen should be administered as needed	1
other individualized ambulatory devices may be indicated	1
carpal tunnel release surgery for carpal tunnel syndrome	1
vitrectomy for vitreous involvement	1
therapeutic phlebotomy	1
periodic phlebotomy (i	1
the usual therapy is weekly phlebotomy	1
camaschella & roetto, unpublished observation]	1
treatment of clinical complications	1
in some cases, joint replacement has been performed	1
diabetes mellitus may require lifelong insulin treatment	1
glycopyrolate or scopolamine to improve drooling	1
standard anticonvulsant medication to control seizures, if present	1
placement of permanent feeding tube to avert malnutrition	1
see also therapies under investigation	1
, 0	1
mild form (th-deficient drd)	1
individuals demonstrate complete responsiveness of symptoms to levodopa treatment	1
individuals show a marked response to levodopa	1
very severe form (th-deficient progressive infantile encephalopathy)	1
individuals are extremely sensitive to levodopa	1
2 to 1	1
long qt interval	1
beta-blockers	1
pacemaker	1
implants	1
respiratory infections	1
the possibility of reduced immune response should be considered	1
surgical release of syndactyly	1
currently there is no definitive treatment	1
management should involve a multidisciplinary team	1
management of trps is principally supportive	1
ectodermal features	1
hair	1
however, reported results vary	1
hands	1
regular simple analgesia (e	1
physiotherapy may aid mobility	1
for trps ii only	1
exostoses	1
restriction of dietary trimethylamine and its precursors	1
choline	1
dietary choline is absorbed through the small intestine	1
trimethylamine n-oxide	1
intake of such vegetables should be restricted	1
use of acid soaps and body lotions	1
trimethylamine is a strong base (pka 9	1
thus, at ph 6	1
0, less than 0	1
02% of trimethylamine exists as the volatile free base	1
sequestering of trimethylamine produced in the gut	1
suppression of intestinal production of trimethylamine	1
enhancement of residual fmo3 enzyme activity	1
counseling	1
affected individuals and their families benefit from counseling	1
see table 3	1
dental crowding /	1
malocclusion	1
dietary diary & calorie counts may be requested	1
gerd and/or constipation	1
standard treatment(s)	1
standard treatment(s) as recommended by neurologist	1
scoliosis / kyphosis	1
standard treatment as recommended by orthopedist	1
effectiveness should be evaluated on an individual basis	1
high-dose thiamine supplementation:	1
invariably improves the hematologic picture	1
additional treatment	1
red blood cell transfusion for severe anemia is indicated	1
treatment has included cochlear implant [hagr 2014]	1
in some instances intrathecal baclofen pumps can be considered	1
dystonia can be managed with:	1
baclofen or intramuscular botulinum toxin when associated with spasticity	1
trihexyphenidyl or tetrabenazine	1
dysarthria may warrant augmentative communication tools	1
anticonvulsant medications should be used when seizures are present	1
subependymal giant cell astrocytomas (segas)	1
additional trials are underway to confirm these preliminary findings	1
renal angiomyolipoma	1
facial angiofibromas	1
cardiac rhabdomyomas	1
, outflow tract obstruction) was surgery	1
however, response to treatment is highly individual	1
oxygen therapy is necessary with impaired lung function	1
persons with severe disease require lung transplantation	1
management guidelines have been published	1
acute management of liver failure	1
nitisinone (orfadin®)	1
nitisinone is generally prescribed at 1	1
0 mg/kg/day	1
individual requirements may vary	1
nitisinone is typically given in two divided doses	1
low-tyrosine diet	1
3 mg/dl)	1
transplant recipients require long-term immunosuppression	1
transplant recipients may also benefit from low-dose (0	1
ocular abnormalities (nystagmus/strabismus)	1
ophthalmologic management	1
oral feeding difficulties	1
g-tube feeding	1
braces and/or corrective surgery	1
self-injurious behavior	1
behavior modification therapy	1
hypo/hypertonia, gross motor delays, sensory processing difficulties	1
physical therapy, occupational therapy	1
absent speech	1
sign language instruction	1
consider alternate forms of communication	1
urinary tract	1
urinary tract infections warrant rapid and complete treatment	1
antibiotic prophylaxis may also be considered	1
bowel	1
constipation is managed as for the general population	1
balance	1
hearing aids are helpful	1
environmental trauma (e	1
, noise) or a genetic susceptibility (e	1
in such individuals, cochlear implantation may be warranted	1
no guidelines exist for the management of vhl lesions	1
cns hemangioblastoma	1
two patients required additional surgery	1
retinal hemangioblastoma	1
renal cell carcinoma	1
3% and 4	1
3%, respectively [young et al 2012]	1
pheochromocytomas	1
pheochromocytomas should be surgically removed	1
laparoscopic approaches have been shown to be effective	1
partial adrenalectomy could be considered	1
one long-term follow-up study (9	1
partial adrenalectomy is also therapy of choice in children	1
in 10 vhl patients 18 successful operations were performed	1
after follow up (median 7	1
pancreatic cysts and neuroendocrine tumors	1
a tumor of ≥3 cm	1
a pathogenic variant in exon 3	1
a tumor with a doubling rate <500 days	1
endolymphatic sac tumors (elst)	1
twenty-nine patients were symptomatic	1
epididymal or broad ligament papillary cyst adenomas	1
physical therapy to promote ambulation	1
treatment is required for any symptomatic vmcm lesion	1
an appropriate dose is 0	1
625 ml/kg) or 150 mg/m2 (3	1
75 ml/m2)	1
desmopressin	1
intranasal preparations are also available	1
intravenous infusion of vwf/fviii clotting factor concentrates	1
in those who are non-responsive to desmopressin (i	1
virus inactivation procedures eliminate potential pathogens	1
indirect treatments	1
fibrinolytic inhibitors (i	1
hormonal treatments (i	1
treatment by vwd type	1
type 1 vwd	1
treatments that directly increase vwf levels (e	1
indirect treatment with fibrinolytic inhibitors or hormones is often effective	1
type 2a vwd	1
indirect treatments can be beneficial	1
type 2b vwd	1
[federici et al 2009]	1
indirect treatments (i	1
, fibrinolytic inhibitors) can be useful	1
type 2m vwd	1
type 2n vwd	1
type 3 vwd	1
desmopressin is not effective in type 3 vwd	1
indirect treatments may also be beneficial	1
vwf levels are higher in the neonatal period	1
pharmacotherapy	1
to reduce or delay side effects (e	1
patients treated with ergot-derived dopamine agonists require periodic echocardiograms	1
droxidopa may be used to treat orthostasis	1
click here for full text	1
management is supportive/symptomatic	1
cleft lip	1
management is surgical, dental, and orthodontic	1
lip pits	1
popliteal pterygium	1
syndactyly may require surgery	1
the genital anomalies may result in infertility	1
refractive error is corrected by spectacles or contact lenses	1
visually disabling cataract is treated by cataract surgery	1
wiskott-aldrich syndrome	1
[buchbinder et al 2014]	1
hematopoietic cell transplantation (hct)	1
eczema	1
topical steroids are the mainstay of therapy	1
autoimmune disease	1
x-linked thrombocytopenia (xlt)	1
, risk of secondary malignancy, infertility)	1
x-linked neutropenia (xln)	1
camptodactyly	1
occasionally toe camptodactyly may require surgical intervention	1
physiotherapy may also be beneficial	1
ligamentous laxity	1
control of type 2 diabetes mellitus	1
use of cholesterol-lowering drugs if lipid profile is abnormal	1
muscle atrophy is a potential complication	1
surgical treatment of ocular cataracts	1
treatment of malignancies in a standard fashion	1
treatment follows routine practices for insulin-dependent diabetes mellitus	1
wfs	1
low-frequency sensorineural hearing loss (lfsnhl)	1
psychiatric difficulties	1
neurogenic bladder	1
treatment of central diabetes insipidus follows routine practices	1
treatment of gastroparesis and celiac disease follows routine practices	1
(see celiac disease	1
sleeping problems	1
if no medical factors (e	1
hepatic adenomas	1
other structural anomalies (e	1
cognitive/behavioral	1
self-calming techniques can help manage anxiety	1
hypertension is usually treated medically	1
hypercalcemia	1
management of hypercalcemia involves the following:	1
hydration status should be assessed	1
increase water intake as indicated	1
but the serum concentration of calcium must be monitored	1
vitamin supplements containing vitamin d should be avoided	1
refractory hypercalcemia may be treated with oral steroids	1
eye, ear, nose, and throat	1
hyperopia is treated with corrective lenses	1
dacrostenosis is treated as in the general population	1
recurrent otitis media may be treated with tympanotomy tubes	1
dental care may require assistance with daily brushing and flossing	1
orthodontic referral should be considered for treatment of malocclusion	1
infants often benefit from feeding therapy	1
urinary tract abnormalities	1
hypothyroidism is treated with oral thyroxine therapy	1
treatment is life long, including during pregnancy	1
d-penicillamine (chelator)	1
pyridoxine must be given along with d-penicillamine	1
zinc (metallothionein inducer)	1
antioxidants	1
, vegetarians) consult with a trained dietitian	1
no specific treatment exists for wss	1
all treatment is symptomatic	1
note: standard replacement hormonal treatment will not promote fertility	1
low igf-1	1
standard treatment	1
l-thyroxine replacement therapy	1
ectodermal	1
treatment is symptomatic and cosmetic only	1
movement disorders	1
benzodiazepines, especially clonazepam	1
its use in wss has not been documented	1
dysarthria	1
consultation with a speech therapist may be helpful	1
nutritional management by a knowledgeable nutritionist is helpful	1
treatment is symptomatic and should be tailored to each patient	1
orthopedic management of leg length discrepancy	1
surgical correction of polydactyly	1
cataract extraction and correction of vision	1
dermatologic management of skin lesions	1
hypohidrosis	1
some individuals may benefit from "cooling vests	1
hypodontia	1
orthodontics may be necessary	1
dental implants in adults can support aesthetic and functional dentition	1
lubrication eye drops can be helpful for dry eyes	1
no formal management guidelines exist	1
the following are general considerations	1
hypogammaglobulinemia is treated with ivig	1
treatment with antiepileptic agents	1
many individuals with periventricular nodular heterotopia have dyslexia	1
pharmacologic treatment of dystonia	1
anticholinergic agents and benzodiazepines	1
the benzodiazepine associated with the best response is clonazepam	1
zolpidem	1
risperidone seems less effective than haloperidol in controlling dystonia	1
pharmacologic treatment of parkinsonism	1
surgical treatment of dystonia and parkinsonism	1
optical devices	1
pharmacologic	1
total parenteral nutrition may be required	1
institute appropriate antimicrobial therapy for infections	1
treat lymphomas and gi cancer	1
the following treatments are recommended:	1
early intervention programs and special education for developmental delays	1
premalignant lesions (e	1
this involves electrodesiccation/curettage or surgical excision	1
calcification of ligaments and tendons	1
however, no controlled studies have been reported	1
recurrent bacterial infections are treated with standard antibiotics	1
standard management is recommended for the following:	1
behavioral and psychiatric problems	1
kyphoscoliosis	1
eye problems	1
testosterone-replacement therapy	1
gynecomastia	1
regression of gynecomastia may occur with testosterone replacement therapy	1
